Crosstalk Between Cytochrome Bc1 Complex and Mitochondrial Matrix Enzymes by Wang, Qiyu
CROSSTALK BETWEEN CYTOCHROME BC1 




   By 
      QIYU WANG 
   Bachelor of Science in Cell and Molecular Biology  
   University of Science and Technology of China 
   Hefei, China 
   2004 
 
   Master of Science in Biochemistry  
   University of Science and Technology of China 
   Hefei, China 
   2007 
 
 
   Submitted to the Faculty of the 
   Graduate College of the 
   Oklahoma State University 
   in partial fulfillment of 
   the requirements for 
   the Degree of 
   DOCTOR OF PHILOSOPHY 
   December, 2011  
ii 
 
  CROSSTALK BETWEEN CYTOCHROME BC1 





   Dissertation Approved: 
 
   Dr. Chang-An Yu 
  Dissertation Adviser 
  Dr. Linda Yu 
 
  Dr. José Luis Soulages 
 
   Dr. Robert L. Burnap 
  Outside Committee Member 
  Dr. Sheryl A. Tucker 







TABLE OF CONTENTS 
 
Chapter          Page 
 
 
I. INTRODUCTION .................................................................................................. 1 
 
 1.1    Introduction of cytochrome bc1 complex ..................................................... 2 
1.1.1 Electron transfer chain............................................................................. 2 
     1.1.2 Complex III ............................................................................................. 5 
     1.1.3 Q-cycle mechanism ............................................................................... 12 
1.1.4 Inhibitors of cytochrome bc1 ................................................................. 15 
     1.1.5 Other functions of cytochrome bc1 complex .......................................... 18 
     1.1.6 Interaction between matrix proteins and electron transfer chain ............. 21 
 1.2    Introduction of Citric Acid cycle enzymes MDH and ACON .................... 22 
     1.2.1 Malate dehydrogenase (MDH) .............................................................. 24 
     1.2.2 Aconitase (ACON) ................................................................................ 26 
 Reference........................................................................................................... 27 
 
 
II. CROSSTALK BETWEEN MITOCHONDRIAL MALATE DEHYDROGENASE 
AND CYTOCHROME BC1 COMPLEX ........................................................... 35 
  
 2.1    Abstract .................................................................................................... 36 
 2.2    Introduction .............................................................................................. 36 
 2.3    Experimental procedures ........................................................................... 38 
 2.4    Results and discussion ............................................................................... 43 
     2.4.1 Mitochondrial soluble matrix proteins increase the activity of cytochrome bc1 
complex   ........................................................................................................... 43 
     2.4.2 Identification of MDH as an interacting protein with the bc1 complex. .. 45 
     2.4.3 Effect of MDH on the activity of the cytochrome bc1 complex .............. 47 
     2.4.4 Binding between MDH and cytochrome bc1 complex ............................ 48 
     2.4.5 Identification of the subunits in bc1 complex that interact with MDH .... 51 
     2.4.6 Cytochrome bc1 complex increases the activity of MDH unidirectionally 
(OAA to malate) ................................................................................................ 53  
2.4.7 Cytochrome bc1 complex changes the enzyme kinetics of MDH ............ 58  
2.4.8 The crosstalk may regulate the mitochondrial bioenergetics .................. 62  
     2.4.9 Discussion about our new precipitation pull-down technique ................. 64  




Chapter          Page 
 
III. ACONITASE SCAVENGES SUPEROXIDE GENERATED FROM THE 
CYTOCHROME BC1 COMPLEX ..................................................................... 73 
 
 3.1    Abstract .................................................................................................... 74 
 3.2    Introduction .............................................................................................. 74 
3.3    Experimental procedures ........................................................................... 75 
 3.4    Results and discussion ............................................................................... 78 
     3.4.1 Identification of aconitase as an interacting protein with the bc1 complex78 
     3.4.2 Identification of the subunits in bc1 complex that interact with aconitase.84 
    3.4.3 Effect on the activities of the cytochrome bc1 complex and aconitase upon 
interaction... ....................................................................................................... 86 
     3.4.4 Aconitase scavenges superoxide generated by bc1 complex. .................. 89 
   3.4.5 The interaction may protect the mitochondria from the damage of superoxide 
 ........................................................................................................................ 91 
 Reference........................................................................................................... 97 
 
III. A NOVEL SHORT MALATE DEHYDROGENASE IN BOVINE 
MITOCHONDRIA .......................................................................................... 100 
 
 4.1    Abstract .................................................................................................. 101 
 4.2    Introduction ............................................................................................ 101 
4.3    Experimental procedures ......................................................................... 103 
 4.4    Results and discussion ............................................................................. 104 
     4.4.1 Comparing the amino sequence of Long and Short MDH. ................... 104 
     4.4.2 RT-PCR confirmed the existence of short MDH. ................................. 106 
     4.4.3 Expression and purification of the long and short forms of MDH. ....... 108 
     4.4.4 Short MDH does not have the normal enzyme activity of long MDH. . 111 
 4.4.5 Short MDH may compete with Long MDH on the binding site of bc1 
complex.. ....................................................................................................  111 
 Reference......................................................................................................... 116 
 
V. CO-CRYSTALLIZATION OF CYTOCHROME BC1 COMPLEX WITH 
MITOCHONDRIAL MALATE DEHYDROGENASE OR ACONITASE ....... 117 
 
 5.1    Abstract .................................................................................................. 118 
 5.2    Introduction ............................................................................................ 118 
5.3    Experimental procedures ......................................................................... 121 
 5.4    Results and discussion ............................................................................. 123 
     5.4.1 The first approach to get the co-crystals. .............................................. 123 
     5.4.2 The second approach to get the co-crystals. ......................................... 128 






LIST OF TABLES 
 
 
Table           Page 
 
1-1  Properties of bovine heart mitochondiral electron transfer complexes ................. 4 
 
1-2  The number of subunits in bc1 complexes from different species ........................ 6 
 
1-3  Compositions and molecular mass of monomeric bc1 complexes. ....................... 7 
 
1-4  Classification of cytochrome bc1 inhibitors. ...................................................... 16 
 
2-1  Effect of mitochondrial matrix extract on the activity of bovine mitochondrial bc1 
complex. .................................................................................................................. 44 
 
2-2  Effect of MDH activity upon interaction with intact and the inhibitor treated bc1 
complex. .................................................................................................................. 57 
 





LIST OF FIGURES 
 
Figure           Page 
 
1-1 Model of the electron transport chain in the mitochondrial inner membrane......... 3 
 
1-2 Structure of the dimeric bovine mitochondrial cytochrome bc1 complex shown in 
ribbon form. .............................................................................................................. 9 
 
1-3 Distance between the redox prosthetic groups in the bovine mitochondrial 
cytochrome bc1 complexes....................................................................................... 11 
 
1-4 The Q-cycle mechanism. ................................................................................... 14 
 
1-5 Structure of some representative inhibitors of the cytochrome bc1 complex. ...... 17 
 
1-6 Relationship between proton motive Q-cycle and the membrane potential regulating 
superoxide cycle in the cytochrome bc1 region of the respiratory chain. ................... 20 
 
1-7 Model for citric acid cycle. ................................................................................ 23 
 
1-8 Ribbon model of malate dehydrogenase (MDH) dimer from the pig (Sus scrofa) with 
NAD as balls. .......................................................................................................... 25 
 
2-1 Identification of MDH as an interacting protein with the bc1 complex................ 46 
 
2-2 Effect of MDH concentration on the bc1 complex activity. ................................ 49 
 
2-3 Surface Plasmon Resonance analysis of the interaction between bc1 complex and 
MDH ....................................................................................................................... 50 
 
2-4 SDS-PAGE and Western blotting of sulfo-SBED cross linked MDH and bc1. .... 52 
 
2-5 Effect of bc1 complex on the activity of forward reaction (from malate to oxalacetate) 
and reversed reaction (from oxalacetate to malate ) of MDH. ................................... 55 
 
2-6 Effect of ionic strength on reverse MDH activity enhancement by bc1. .............. 56 
 




2-8 Lineweaver Burk plots for the MDH reverse directional activity by OAA.......... 61 
 
2-9 The schematic illustration for the crosstalk between MDH and bc1 Complex. .... 63 
 
3-1 Identification of Aconitase as an interacting protein with the bc1 complex. ........ 79 
3-2 SDS-PAGE and Western blotting of biotin-labeled aconitase pulled down by bc1 
complex in high salt and calcium containing solution .............................................. 81 
 
3-3 Western blotting of biotin-labeled aconitase pulled down by reduced and oxidized bc1 
complex... ................................................................................................................ 83 
 
3-4 SDS-PAGE and Western blotting of sulfo-SBED cross linked Aconitase and bc185 
 
3-5 Effect of bc1 complex on the activity of aconitase. ............................................. 87 
 
3-6 Time courses of cytochrome b and c1’s reduction by Q0C10BrH2. ...................... 88 
 
3-7 Effect of aconitase on the superoxide generation by the mitochondrial (A and ■ in C) 
or bacterial (B and ● in C) bc1 complex.  . ............................................................... 90 
 
3-8 Comparison of superoxide generation from mitochondrial and bacterial bc1 complex.  
. ............................................................................................................................... 94 
 
3-9 The schematic illustration for the aconitase and bc1 complex in the cell.. ........... 96 
 
4-1 Amino acid sequence analysis for Long and Short MDH from bovine mitochondria.  
 .............................................................................................................................. 105 
 
4-2 RT-PCR result of the Long and Short MDH from bovine cell. ......................... 107 
 
4-3 Schematic representation of the proteins used in this study. ............................. 109 
 
4-4 SDS PAGE and western blotting results of the Long and Short MDH. ............. 110 
 
4-5 MDH activity assay in the forward and reverse directions. ............................... 112 
 
4-6 Long and short MDH’s effect on the activity of bc1 complex. .......................... 113 
 
4-7 SDS-PAGE result of the short MDH pulled down by bc1 complex in low and high 
solutions ................................................................................................................ 115 
 
5-1 3-D structures of the mitochondrial bc1 complex, malate dehydrogenase and 
aconitase.. .............................................................................................................. 119 
 
5-2 SDS-PAGE of the purified mitochondrial bc1 complex, malate dehydrogenase and 
viii 
 
aconitase ................................................................................................................ 124 
 
5-3 Crystals of mitochondrial bc1 complex in the present of malate dehydrogenase and 
aconitase. ............................................................................................................... 125 
 
5-4 SDS-PAGE of the co-crystals for the mitochondrial bc1 complex together with malate 
dehydrogenase and aconitase after being dried on the filter paper. ......................... 126 
 
5-5 SDS-PAGE of the co-crystals for the mitochondrial bc1 complex together with malate 
dehydrogenase and aconitase after being washed in the solution. ........................... 127 
 















1.1 Introduction of cytochrome bc1 complex 
1.1.1 Mitochondrial Electron transfer chain  
Mitochondria, also known as the "cellular power plants", generate more than 90% of 
energy required for eukaryotic organisms, through a process called oxidative phosphorylation. 
This process is carried out in the inner membrane of mitochondria and by a series of 
complexes. They are: Complex I (NADH-Q Oxidoreductase), Complex II (Succinate- Q 
Oxidoreductase), Complex III (ubiquinol-Cyt c Oxidoreductase), Complex IV (cytochrome c 
oxidase) and Complex V ( ATP synthase) (Fig.1-1). The first four complexes are electron 
transfer complexes. They catalyze sequential electron transfer from NADH or succinate to 
ubiquinone, then from ubiquinol to cytochrome c (cyt c) and finally from cyt c to molecular 
oxygen respectively. The electrons transferred through Complex I, III and IV is with 
concomitant translocation of protons across the inner mitochondrial membrane to generate 
the proton gradient and membrane potential for ATP synthesis by Complex V.   
All the five complexes have been isolated and purified from submitochondrial particle 
preparation. Purified Complex I contains 45 protein subunits with 10 redox centers: 1 FMN 
and 9 iron sulfur clusters. Complex II contains 4 protein subunits with 1 FAD, 3 FeS clusters 
and 1 heme b560. Complex III contains 11 proteins subunits with two b-type hemes (bH and bL 
) , one c-type heme (c1), and one [2Fe2S] cluster. Complex IV contains 13 protein subunits 
with a-type hemes (a and a3) and two Copper centers (CuA and CuB). Complex V, the 









Fig.1-1 Model of the electron transport chain in the mitochondrial inner membrane. 
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The most significant progress in the study of mitochondrial oxidative phosphorylation is 
the success of crystallization of these complexes in the recent years.  
 
1.1.2 Complex III (cytochrome bc1 complex) 
 Complex III, also known as cytochrome bc1 complex, is an essential electron transfer 
complex. It catalyzes electron transfer from ubiquinol to cyt c with translocation of 2 
proton/e from matrix to mitochondrial inter membrane space to generate the electrochemical 
gradient for ATP synthesis. This protein was first isolated from submitochondrial particles 
(SMP) of beef heart by Dr. Youssef Hatefi in 1970s. And then our group modified the 
purification procedures to obtain a better preparation. The major steps involved in 
purification procedures are potassium deoxycholate solubilization, followed by ammonium 
acetate fractionation, then centrifugation.     
Purified bovine Complex III contains 11 protein subunits. Three of them, cyt b, cyt c1 
and ISP house two b hemes, one c1 heme and a [2Fe2S] cluster. These three essential 
subunits are called core subunits and they exist in all cytochrome bc1 complexes, from 
Rhodobacter capsulatus to bovine mitochondria (9). The other 8 subunits containing no 
redox prosthetic centers are the supernumerary subunits. The number of supernumerary 
subunits in the bc1 complex varies from 0 to 8 (Table 1-2, 1-3). The core subunits are 
essential for catalytic function of the complex whereas the supernumerary subunits are likely 


















Bovine 11 3 8 
Chicken 10 3 7 
Potato 10 3 7 
Yeast 10 3 7 
Rhodobacter 
sphaeroides 
4 3 1 
Rhodobacter 
capsulatus 












Table 1-3 Compositions and molecular mass of monomeric bc1 complexes (10) 
Subunit Beef No. res. Yeast No. res R. sph No. res
1 core 1 446 COR 1 431 - -
2 core 2 439 COR 2 352 - -
3 cyt. b 379 COB 385 cyt b 445
4 cyt. c1 241 CYT1 249 cyt c1 286
5 ISP 196 RIP1 185 ISP 187
6 QPK 111 QCR7 126 - -
7 QPC 81 QCR8 93 sub4 124
8 c1-hinge 78 QCR6 122 - -
9 ISP 
precursor
78 - - - -
10 c1 assoc. 62 QCR9 52 - -
11 unnamed 56 QCR10 78 - -
No. res. / monomer 2,167 2,073 1,042









Study of mitochondrial cytochrome bc1 complex was highlighted when the first 3-D 
structure of bovine bc1 complex was available in 1997, by a joint effort of our group and 
Deisenhofer’s group (Fig.1-2). The 3-D structure of bc1 complex was diffracted at X-ray to 
2.9 Å resolution and it exists as an intertwined dimer with each monomer containing 11 
protein subunits. The head domain of ISP in one monomer is connected to the tail domain of 
ISP in the other monomer. The structure is 130 Å in width and 155 Å in height.  It can be 
divided into three regions: matrix, trans-membrane, and the inter-membrane space regions 
(see Fig. 1-2). 
The matrix region of the molecule occupies more than one-half of the molecular mass 
and extends 75 Å from the transmembrane helices.  Subunits I, II, VI, IX, C-terminal part of 
ISP and the N-terminal of subunit VII are in this region.  The transmembrane region (42 Å) 
in each monomer consists of 13 transmembrane helices, 8 of which are from cytochrome b, 5 
from cytochrome c1, ISP, subunit VII, X, and XI, respectively.  The cytochrome b houses 
two b type hemes, bL and bH; and two Q-binding pockets, QN and QP in the transmembrane 
region.  The intermembrane space region extends 38 Å, housing cytochrome c1 and ISP 











Fig.1-2  Structure of the dimeric bovine mitochondrial cytochrome bc1 complex shown in 
ribbon form. The color code for each subunit is given on the side bar. The boundary of 
mitochondrial inner membrane is delineated by two parallel lines. The mitochondrial inter-
membrane space (IMS), the transmembrane (MIM, mitochondrial inner-membrane) and the 





 The distance between heme irons in bL, bH, c1, and the iron-sulfur cluster in the bc1 
complex is shown as Fig.1-3. It is 21 Å from heme bL to bH, 27 Å from heme bL to [2Fe2S] 
cluster and 31 Å from the [2Fe2S] cluster to heme c1. Low electron density region shown in 
the inter-membrane part of bc1 complex represents the ISP head domain in the structure (11). 
The observation that the distance between heme c1 and [2Fe2S] is too far for an effective 
electron transfer, together with the finding that the electron density for the ISP head domain 
is particularly poor, indicate the movement of ISP. This movement was also further 















Fig.1-3 Distance between the redox prosthetic groups in the bovine mitochondrial 










1.1.3 Q-cycle mechanism  
The “protonmotive Q cycle” mechanism is the most popular hypothesis for the electron 
and proton transfer in the cytochrome bc1 complex. It was first proposed by Dr. Peter 
Mitchell and then modified by Dr. Trumpower(13-21). The main feature of this mechanism 
is the presence of the Q binding sites: Q oxidative (Qo or QP) and Q reductive (Qi or QP) sites, 
and the bifurcation of electrons from QH2 at the QP site (see Fig.1-4).   
In the Q cycle, the reduced Q (quiquinol, QH2) binds the QP pocket, and transfers its 
electrons either sequentially or concertedly to ISP and heme bL. With the ISP head domain 
movement, ISP transfers one electron from ISC (iron sulfur cluster) to the heme c1 of cyt c1, 
and then from heme c1 to the heme c of cytochrome c.  The other electron is transferred from 
heme bL to bH, and then to the Q or SQ at the QN site. The catalysis of bc1 complex couples 
proton pumping from mitochondrial matrix to intermembrane space to the electron transfer.  
In the QP pocket, with the bifurcation oxidation of QH2, four protons from two QH2 are also 
pumped into intermenbrane space simultaneously. And in the QN pocket, one oxidized Q 
receives two electrons (one each time) from heme bH totally during the catalysis, and this re-
reduced Q uses two protons in mitochondrial matrix to form a new QH2. Then this new QH2 
goes to the QP pocket for next Q cycle. Therefore, the overall reaction catalyzed by bc1 
should be the equation (a) below: 
QH2 + 2 Cyt c3+ +2H+(N)    Q + 2 Cyt c2+ + 4H+(P) 
In all, the whole Q cycle pumps four protons into the inter membrane space, use two 
protons in the matrix, oxidize one ubiquinol to ubiquinone, and reduce two cytochrome c.  
13 
 
There are two hypotheses for bifurcated QH2 oxidation at the QP site. They are the 
“sequential” (22-24) and “concerted” (25-28) mechanisms. In the “sequential” mechanism, 
the first electron from QH2 is transferred to ISC, and then the ubisemiquinone is produced 
and used to reduce heme bL. In the “concerted” mechanism, the two electrons are 
simultaneously transferred from QH2 to ISC and heme bL.  
However, the fact that no ubisemiquinone radical can be detected at the Qp site (SQp) 
(29, 30) questions the validity of the sequential oxidation mechanism. Several reasonable 
explanations for the absence of Q radical have been proposed (22, 24) such as 
antiferomagnetic coupling between SQp and ISC or SQp being fastly oxidized by heme bL. It 
was reported that the SQp under abnormal conditions can be detected (31, 32), but this has 
not been confirmed by other investigators. The absence of SQp in a mutant bc1 complex 
without heme bL further confirms that SQp is not involved in QH2 oxidation at the Qp site 
(30). So far there is no evidence to show that ISC can receive an electron from QH2 before 
the other redox components. Therefore, developing a technique for simultaneously 
determining the reduction rates of ISC and heme bL is a breakthrough in the mechanistic 
study of the bc1 complex (28). It is likely that the concerted mechanism can really give a 
more reliable explanation for the electron transport at the QP site so far. This will be more 
accurate when we can get the bc1 complex structure including the exact QH2 binding 










Fig.1-4 The Q-cycle mechanism. (A) Sequential bifurcated oxidation of quinol at Qp site. (B) 






1.1.4 Inhibitors of cytochrome bc1 
Cytochrome bc1 inhibitors can be classified into three major classes based on the 
differences in the binding sites (38-40, Table 2). They are: class I hibitors (also called class 
P), which bind to QP pocket and block ubiquinol oxidation or the electron transfer from ISP 
to cytochrome c1; class II (also called class N), which bind to the QN site and prohibit the 
electron transfer from heme bH to ubiquinone;  class III (also called class PN ), which bind to 
both QP and QN sites and cause all the inhibitions. (34-36). Table I-4 and Figure I-5 show 
these three classes of inhibitors and their chemical structures respectively.  
Class I inhibitors can also be sub-classified into three groups: Ia, Ib and Ic. A beta-
methoxyacrylate (MOA) group is a typical structural element in class Ia inhibitors. When 
class Ia inhibitors bind to cytochrome b, a red-shift in the α and β-bands of the reduced heme 
bL spectrum is observed. Myxothiazol and β-methoxyacrylate stilbene (MOAS), which block 
electron transfer from ubiquinol to ISP, are typical class Ia inhibitors.  A chromone ring 
system exists in Class Ib inhibitors. The binding of Ib inhibitors results in a remarkable 
increase of ISP mid-point potential and induce a red-shift of cytochrome bL spectrum. 
Stigmatellin, a typical class Ib inhibitor, inhibits the electron transfer from ISP to cytochrome 
c1. Class Ic inhibitors are 2-hydroxy quinone analogues. They cause a slight increase in ISP 
redox potential shift but show no influence on the spectrum of cytochrome bL. UHDBT is a 
typical Ic inhibitor. Antimycin A and diuron are two typical inhibitors of class II (N). Class 





Table 1-4. Classification of cytochrome bc1 inhibitors.(37) 
Class              Subgroup            Representative inhibitors 
    Ia             Myxothiazol, MOAS 
I (QP site)                         Ib            Stigmatellin 
    Ic             UHDBT 
II (QN site)                                   Antimycin A, diuron 
PN (QP and QN)                           NQNO, funiculosin 
NQNO: 2-n-nonyl-4-hydroxyquinoline N-oxide; 
MOAS: methoxyacrylate-stilbene; 











1.1.5 Other functions of mitochondrial bc1 complex (MPP and Superoxide generating 
activities)  
In addition to electron and proton transfer activity, the bovine bc1 complex also have 
mitochondrial processing peptidase (MPP) like activity (41, 42). The comparison of core I 
and core II with α and β subunits of MPP, shows some sequence homology. A sequence of 
Y91XXE94H95(X)76E171(11) in core I is similar to the MPP’s zinc-binding motif 
HXXEHX76E on its β-subunit. Further-more, residues K300 and R301 of core II are structurally 
close to this zinc-binding motif in core I and may play a role in the active site. Triton X-100 
can activate the MPP acivity of bovine bc1 complex. It disrupts the structural integrity of the 
complex, and so the binding of the inhibitory polypeptide to core I&II is weakened.(41) 
During the maturation of bc1 complex, the presequence peptide of ISP is cleaved by core 
I&II, and then it is bound to them as subunit IX and thus inhibits MPP activity.  Since the 
binding of subunit IX inhibits the MPP activity of core I and core II, they function as a 
suicide peptidase. 
During electron transfer through complex III, superoxide generation is observed. 
Mitochondrial electron transfer chain is a major source for cellular superoxide production 
(43). Electrons transferring through Complex I and III generate superoxide anion  (44). In 
complex I, the electron donors for superoxide generation are the flavin radical and the 
ubiquinone radical. In bc1 complex, the ubisemiquinone radical at the QP site (45) and/or the 
reduced heme b566 (or bL) (46) are believed to be the electron leakage sites for superoxide 
production during bc1 complex catalysis.(see Fig. 1-6)  
19 
 
Although O2.- production through bc1 complex might result from electron leakage from 
their normal pathways, the reaction mechanism of O2.-  generation remains elusive. Under 
normal catalytic conditions, the electrons which leak from bc1 to form O2.-  account for only a 
very small amount(47, 48). But this O2.-  generating activity increased when there was 
antimycin or the electron transport chain (ETC) was over reduced (48). Our most recent 
results found that neither SQp nor reduced heme bL was the site of electron leakage (30). O2 
functions as a low potential electron acceptor to be involved in bifurcated oxidation of QH2 
in a hydrophobic environment and in the absence of heme bL when there is a high protential 
acceptor, ISP. Protonated superoxide is produced and diffused to a hydrophilic environment 
(intermembrane space or matrix), and finally becomes O2.- by deprotonation. 
In most kinds of organisms, “oxidative stress” can cause extensive toxicities. In this 
oxidative stress, the reactive oxygen species (ROS) reacts with cellular components (such as 
DNA/RNA, proteins, carbohydrates, and unsaturated lipids), generate non-reversible damage 
to them. The ROS can make the iron-sulfur clusters of complexes I and III inactive, thus 
restrain electron transport in mitochondria, and limit the mitochondrial respiration (49). ROS 
damages take part in many disease states, such as inflammation, ischemia-reperfusion injury, 











Fig.1-6. Relationship between the membrane potential regulating superoxide cycle and 
proton motive Q-cycle in the cytochrome bc1 region of the respiratory chain. Abbreviations 
used are: SOD, superoxide dismutase; PUSFA, polyunsaturated fatty acyl groups of lipids; 
UHDBT, 5-undecyl-6-hydroxyl-4,7- dioxobenzothiazol; Gpx, glutathione peroxidase; Cat, 









1.1.6 Interaction between matrix proteins and electron transport chain 
After more than a decade of intensive post 3-D structure studies, only a handful 
structure/function questions remain unsettled. We anticipate that the next phase of study of 
the bc1 complex will be the integration of this complex into a larger bioenergetics scheme 
that includes the regulation of and interaction with TCA cycle enzymes as well as the redox 
linked signal transduction (56, 57).  
So far, no study on the interactions between electron transport chain complexes and 
soluble matrix enzyme has been conducted. The only enzyme that participates in both the 
citric acid cycle and electron transport chain is Complex II (58).  It catalyzes succinate to 
fumarate with electron transferred to Q. Some other enzymes of TCA cycle are only known 
to couple with electron transfer chain through their product NADH at complex I (59). No 
direct interaction between them has been reported yet.  
We have recently developed a simple precipitation pull-down technique for studying the 
interaction between bc1 and matrix enzymes. Three proteins have been pulled down by the 
bc1 complex and identified as bemitochondrial malate dehydrogenase (MDH), asparate 
transaminase and aconitase, based on peptide mass fingerprinting analysis. The study of the 
interaction between MDH or aconitase and bc1, its binding sites as well as its roles in 






1.2 Introduction to Citric Acid cycle enzymes MDH and ACON 
The citric acid cycle is also named as the TCA cycle ( tricarboxylic acid cycle) or Krebs 
cycle. A series of enzyme-catalysed chemical reactions are included in TCA cycle and it is 
crucial to all living cells using oxygen in cellular respiration. It accounts for the oxidation of 
acetyl CoA derived from amino acids, carbohydrates and fat acids and generates numerous 
biosynthetic precursors. In eukaryotes, the citric acid cycle occurs in the mitochondrial 
matrix region.  
The eight enzymes of the citric acid cycle catalyze a series of well-known reactions 
(shown as Fig. 1-7). Two enzymes, aconitase and malate dehydrogenase, which were co-

























1.2.1 Malate dehydrogenase (MDH) 
Malate dehydrogenase (EC 1.1.1.37) catalyzes the final reaction of the citric acid cycle, 
which converts malate into oxaloacetate. The reaction is NAD+-dependent and oxidizes 
malate’s secondary hydroxyl group to a corresponding ketone(60). And this reaction is 
reversible.  There are two types of malate dehydrogenase: one in cytosolic,the other in 
mitochondria. 
The 3-D structure of mitochondrial malate dehydrogenase from porcine heart has already 
been obtained. And in this MDH crystal structure, it contains four identical subunits in the 
asymmetric unit of a monoclinic cell.(61) 
Besides the TCA cycle, MDH also participates in the malate-aspartate shuttle, 
translocating electrons produced during glycolysis across the mitochondrial inner membrane. 
There are two forms of malate dehydrogenase in the shuttle system: mitchondrial malate 
dehydrogenase and cytosolic dehydrogenase. In the cytosol, malate dehydogenase catalize 
the reaction of oxaloacetate and NADH to produce malate and NAD+. Then malate will be 
imported into the mitochondrial matrix by the Malate-alpha-Ketoglutarate antiporter and 
meanwhile alpha-ketoglutarate be exported from the matrix into the cytosol. Once get into 
matrix, mitochrondrial malate dehydrogenase will convert malate into oxaloacetate. And 









Fig.1-8  Ribbon model of malate dehydrogenase (MDH) dimer from the pig (Sus scrofa) 










Malate dehydrogenase also participated in gluconeogenesis, in which glucose is 
synthesized from smaller molecules. Malate dehydrogenase reduces the oxaloacetate to 
malate, which is able to be transported through the inner mitochondrial membrane. Then 
malate can be oxidized by cytosolic malate dehydrogenase to form oxaloacetate again and 
phosphoenol pyruvate carboxy kinase (PEPCK) converts oxaloacetate to phosphoenol 
pyruvate finally. (63) 
1.2.2 Aconitase (ACON) 
Aconitase (EC 4.2.1.3) catalyses the reversible isomerization between citrate and 
isocitrate via cis-aconitate as the intermediate. It is a non-redox-active process. A covalently 
bound [4Fe-4S] iron-sulfur cluster is needed for the catalytic activity of aconitase.  
Most of the other iron-sulfur proteins which mainly function as electron carriers, but the 
iron-sulfur cluster of aconitase reacts directly with an enzyme substrate. It has an active 
[Fe4S4]2+ cluster, which may change to an inactive [Fe3S4]+ form. This [Fe4S4] centre has 
been shown to be coordinated with three protein Cys sulfhydryl groups. The labile iron ion of 
the [Fe4S4] cluster is coordinated by water molecules (not Cys) in the active state. Aconitase 
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The interactions between the mitochondrial cytochrome bc1 complex and matrix 
soluble proteins were studied by a precipitation pull-down technique. Purified, detergent 
dispersed bc1 complex was incubated with mitochondrial matrix proteins followed by 
dialysis in the absence of detergent. The interacting protein(s) was co-precipitated with 
bc1 complex upon centrifugation.  One of the matrix proteins pulled down by bc1 
complex was identified as mitochondrial malate dehydrogenase (MDH) by MALDI-TOF 
Mass spectrometry and confirmed by Western blotting with anti-MDH antibody. Using 
cross linking technique, subunits I, II (core I & II) and V of the bc1 complex were 
identified as the interacting sites for MDH. Incubating purified MDH with the detergent 
dispersed bc1 complex results in an increase of the activities of both the bc1 complex and 
MDH. The effect of the bc1 complex on the activities of MDH is unidirectional 
(oxalacetate → malate). These results suggest that the novel crosstalk between citric acid 
cycle enzymes and electron transfer chain complexes might play a regulatory role in 
mitochondrial bioenergetics. 
2.2 Introduction 
The mitochondrial cytochrome bc1 complex catalyzes electron transfer from 
ubiquinol to cytochrome c with the concomitant translocation of protons across the 
membrane to generate a proton gradient and membrane potential for ATP synthesis (1). 
Although the structural and functional studies of the mitochondrial bc1 complex have 
been intensive, few studies of the interactions between the bc1 complex and the soluble 
matrix enzymes have been available. Complex II (succinate-ubiquinone oxidoreductase) 
37 
 
is the only enzyme that participates in both the citric acid cycle and the electron transport 
chain (2). Complex II is composed of a succinate-dehydrogenase, which is a citric acid 
cycle enzyme, and a membrane anchoring protein fraction, which houses ubiquinone. 
Complex II catalyzes the oxidation of succinate to fumarate and the reduction of 
ubiquinone to ubiquinol. Other enzymes of citric acid cycle are known to couple to the 
electron transfer chain through their product NADH at complex I (3).   
Structurally the mitochondrial bc1 complex can be divided into three regions: matrix, 
trans-membrane, and the inter-membrane space regions. The matrix region contains 
subunits I (core I), II (core II), VI, IX, and the N-terminal part of subunits V (ISP) and 
VII (4, 5). Although this region contains the major part of the complex mass, it possesses 
no redox centers; it is not directly involved in electron/proton transfer activity. The 
functions of subunits in this region, although, mostly unknown, may contribute to a 
structural or regulatory role of the bc1 complex. If the interaction between the matrix 
enzymes and the bc1 complex exists, this region would be a good choice for the contact.  
In the present work, we have observed an increase in bc1 activity when the bc1 
complex was incubated with the mitochondrial soluble matrix protein fraction, suggesting 
that an interaction between the electron transfer complex and the matrix enzymes exists.  
To confirm this suggestion, we developed a technique to pull down the interacting matrix 
proteins. This technique involves incubation of the purified, detergent dispersed bc1 
complex with the soluble matrix enzymes fraction followed by extensive dialysis and 
centrifugation to collect the precipitates that contain the matrix enzymes and the bc1 
complex. One of the matrix enzymes pulled down with the bc1 complex has been 
identified as MDH.  Herein we report the detailed procedures for pulling-down the matrix 
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enzymes that interact with the cytochrome bc1 complex and the identification of MDH as 
one of the matrix enzymes that interacts with bc1 complex. The effect of the interaction 
on the activities of the bc1 complex and MDH, as well as the likely interacting domain, 
was also investigated.  
2.3 Experimental procedures 
Chemicals- Cytochrome c (horse, type III), sodium cholate, deoxycholate, NADH, 
oxaloacetate (OAA), Malate, NAD, and bovine MDH were purchased from Sigma. Cross 
linker, Sulfo-SBED (Sulfosuccinimidyl-2- [6-(biotinamido)-2-(p-azidobenzamido) hexa- 
noamido ] ethyl-1,3´- dithiopropionate) was purchased from Pierce. 2,3-Dimethoxy-5-
methyl-6-(10-bromodecyl)-1,4-benzoquinol (Q0C10BrH2) was prepared as previously 
reported (6). Inhibitor chlorothricin was purchased from A.G. Scientific. Stigmatellin and 
Antimycin A were purchased from Sigma. The concentrations of stigmatellin and 
antimycin A were determined spectrophotometrically using millimolar extinction 
coefficients of 65.5 cm−1 mM−1 and 4.8 cm−1 mM−1, respectively (7). 
Cytochrome bc1 complex preparation and activity assay- Bovine heart mitochondrial 
cytochrome bc1 complex was prepared as previously reported (8, 9). The purified 
complex contained 9.3 nmol of cytochrome b and 4.9 nmol of cytochrome c1 per 
milligram of protein.  It was dissolved in a TS buffer (50 mM TrisHCl buffer, 0.66 M 
sucrose, pH 8.0) to a protein concentration of 22 mg/mL and frozen at −80 °C until use. 
The concentrations of cytochromes b and c1 were determined spectrophotometrically 
using millimolar extinction coefficients of 28.5 cm−1 mM−1 (10) and 17.5 cm−1 mM−1 
(11), respectively.  
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For activity determination, the cytochrome bc1 complex was diluted with 50 mM 
phosphate buffer, pH 7.4, containing 1mM EDTA and 0.01% KDOC to a protein 
concentration of 0.022 mg/mL. Diluted protein solution (10 μL) was added to 990 μL of 
an assay mixture (100 mM phosphate buffer, pH 7.4, 1 mM EDTA, 1 mM KCN, 100 μM 
cytochrome c and 25 μM Q0C10BrH2).  Activity was determined by measuring the 
reduction of cytochrome c in a Shimadzu UV-2401PC spectrophotometer at 25 °C using 
a millimolar extinction coefficient of 18.5 cm−1 mM−1 (11) for calculation. The non-
enzymatic oxidation of Q0C10BrH2 determined under the same conditions in the absence 
of the enzyme was subtracted from the assay. The bc1 complex used in these experiments 
had a specific activity of about 12 μmol cytochrome c reduced/min/nmol cytochrome b. 
Preparation of mitochondrial matrix proteins- Three pounds of fresh, fat and 
connective tissue free beef heart muscles were cut into small pieces and then 
homogenized with matrix protein buffer (20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 10 mM KCl, 1.5 mM MgCl2, 1 mM 
ethylenediaminetetraacetic acid (EDTA), 1 mM ethylene glycol tetraacetic acid (EGTA), 
1 mM Dithiothreitol (DTT), 0.1mM phenylmethylsulphonyl fluoride (PMSF), 250 mM 
sucrose, pH 7.4) on ice. The homogenate was centrifuged at 600 ×g for 10 min at 4 oC. 
The supernatant was collected and centrifuged at 8000 ×g for 15 mins at 4 oC. The 
supernatant and light-colored fluffy upper layer of precipitate were discarded. The dark 
red precipitate was collected, suspended in the 100 mL matrix protein buffer, and 
centrifuged at 8000 ×g for 15 mins at 4 oC. The light-colored supernatant solutions were 
discarded and the dark red precipitates were suspended in the 50 mL matrix protein 
buffer. The mitochondria were then broken with sonication for 5 min at 0 oC. The 
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mixture was centrifuged at 100,000 ×g for 2 hours at 4 oC. The upper floating lipids and 
precipitates were discarded and the supernatant solution was collected and subjected to 
centrifugation at 200,000 ×g for 2 hours at 4 oC. The supernatant (the matrix protein 
fraction) has a protein concentration of 7.5 mg/mL and was stored at -80 oC until use. 
Protein concentration was determined by the Bradford protein assay with crystalline 
bovine serum albumin (BSA) as the standard. 
The pull down experiment- One mg of bc1 complex was incubated separately with 1 
mL 0.28, 0.83 and 2.50 mg/mL of mitochondrial matrix extract on ice for 2 hours. After 
incubation, the mixtures were dialyzed against 1 L of the matrix protein buffer for 4 
hours with one change of buffer at 4 oC to remove the detergent used for dispersing the 
cytochrome bc1 complex. The dialyzed preparations were subjected to centrifugation at 
100,000 ×g for 1 hour at 4 oC. The resulting precipitates were dissolved in the PES buffer 
(50 mM phosphate buffer, 1 mM EDTA, 0.5% sodium cholate, pH7.4) and analyzed by 
SDS-PAGE. The matrix protein fraction and the cytochrome bc1 complex alone were 
subjected to identical dialysis and centrifugation conditions as those described and used 
as controls. 
MDH Activity assay- A conventional spectrophoto- metric method was used for 
MDH activity assays (Malate + NAD+ ↔ Oxaloacetate + NADH + H+) (12-14). The 
reversed reaction of MDH was assayed using 0.2 mM NADH and 0.2 mM OAA in a 50 
mM phosphate buffer (pH 7.4). The forward reaction of MDH was assayed using 2 mM 
NAD and 2 mM malate in a 50 mM phosphate buffer (pH 7.4). The activity was 
determined by measuring the decrease or increase of NADH absorbance at 340 nm, in a 
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Shimadzu UV-2401PC spectrophotometer at 25 °C using a millimolar extinction 
coefficient of 6.22 cm−1 mM−1. 
Mass Spectroscopy- Samples were run with SDS-PAGE first. The selected protein 
bands were sliced from the gel and washed with 50% acetonitrile /25 mM ammonium 
bicarbonate (pH8.0) three times, for 40 min each. The washed gel slices were dehydrated 
by acetonitrile. In-gel digestion was carried out with 8 µg/mL of freshly prepared trypsin 
in 50 mM of ammonium bicarbonate (pH8.0) on ice for half an hour. The final sample 
was mixed with the light absorbing compound (10 mg/mL of alpha-cyano-4-hydroxycin- 
namic acid dissolved in 0.3 mL of 50% acetonitrile / 0.1% trifluoroacetic acid (TFA)) and 
loaded on the MALDI plate to co-crystallized (dried). Data was collected from the 
MALDI-TOF MS (Voyager-DETM PRO Biospectrometry Workstation ) and the 
intensities within 10% of the main peak were set as noises and not shown with a peak 
marker. The monoisotopic masses of the first peaks of the main clusters were collected. 
The unknown protein was searched within mammalian proteins of MSDB database with 
software Mascot Daemon, using the tolerance of +100 ppm.  
Surface Plasmon Resonance (SPR)- SensíQ from ICX Nomadics is a dual-channel, 
semi-automated surface plasmon resonance system.  250 µl of MDH (100 μg/mL) were 
used to bind with channel 1 (channel 2 as control) in the COOH chip until it reached 
balance at 2000Ru. Various concentrations of bc1 complex in a dilution buffer (50 mM 
phosphate buffer, pH 7.5, containing 0.01% KDOC) were injected through both channel 
1 and 2. The sample dilution buffer was used as the flowing buffer over the chip all the 
time except for during the bc1 complex sample injection time. Data was analyzed by the 
software Qdat from the same SPR manufacture company.  
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Cross linking-  Sulfo-SBED (Sulfosuccinimidyl -2-[6-(biotinamido)-2-(p-
azidobenzamido)hexanoamido] ethyl-1,3´-dithiopropionate) is a trifunctional cross- 
linking reagent containing a biotin, a sulfonated N-hydroxysuccinimide (Sulfo-NHS) 
active ester, and a photoactivatable aryl azide. First, the amine-reactive Sulfo-NHS ester 
of Sulfo-SBED was created on the carboxyl-containing amino acids on the surface of 
MDH. After dialysis to remove the nonreacted Sulfo-NHS, labeled MDH was mixed with 
bc1. The mixture was illuminated with a long-wave UV lamp (365 nm) at a distance of 5 
cm for 15 minutes. The disulfide bond in the spacer arm originally attached to the Sulfo-
NHS ester was cleaved by incubating it with 100 mM of β-mercaptoethanol. The final 
biotin-labeled proteins were subjected to Western blotting analysis.  
Western blotting- Western blotting was performed with biotin labeled polyclonal 
rabbit antibodies against bovine mitochondrial MDH. The polypeptides separated by 
SDS-PAGE gel were transferred to a 45 μm nitrocellulose membrane for 
immunoblotting. Strepavi- din conjugated to horseradish peroxidase (HRP) was used as 










2.4 Results and discussion 
2.4.1 Mitochondrial soluble matrix proteins increase the activity of cytochrome bc1 
complex.   
In searching for possible interactions between the electron transfer complexes and 
the mitochondrial matrix proteins, we found that the electron transfer activity of 
mitochondrial cytochrome bc1 complex increases in the presence of bovine mitochondrial 
matrix extract (Table 2-1).  The involvement of phospholipids in the matrix extract to 
activate the bc1 complex was ruled out, as the addition of phospholipase A-treated matrix 
extract give the same level of bc1 activity increase as that of untreated matrix extract. 
However, when the mitochondrial matrix extract was heated to 95 °C and then incubated 
with the bc1 complex, no activity increase was observed, suggesting that some proteins in 
the matrix extract play the activation role. This suggestion was further confirmed by the 
observation that the proteinase digested matrix extract showed no activation on the 
activity of bc1 complex. Since the purified cytochrome bc1 complex contains no other 
proteins besides the subunits of the complex, it is likely that some matrix proteins, which 
are capable of activating the bc1 complex, might be physically associated with the 
complex in vivo and then dissociated from the bc1 complex during the purification steps.  
The use of multiple steps of salt fractionation/ precipitation in the presence of detergents 










Table 2-1.  Effect of mitochondrial matrix extract on the activity of bovine 




(μmol Cyt c reduced/min/ nmol Cyt b) 
Activity  
(%)b 
bc1 + buffer 12.00 ± 0.24 100 ± 2 
bc1 + MP 15.84 ± 0.24 132 ± 2 
bc1 + (MP + PLA2) 15.60 ± 0.36 130 ± 3 
bc1 + denatured MP 11.88 ± 0.86 99 ± 7 
 
a Purified bc1 complex were incubated with mitochondrial matrix extract (MP) or treated MP 
for 20 min at 4 ˚C before ubiquinol-cytochrome c reductase activity was determined. Buffer, 
MP preparation buffer as control; (MP + PLA2), MP was treated with phospholipase A2 for 
30min first; denatured MP, MP was heated at 95 ˚C for 30 min and then centrifuged to 
discard the precipitate.  
b 100% activity represents 12 μmol cytochrome c reduced/min/ nmol cytochrome b at 23 ˚C. 










2.4.2 Identification of MDH as an interacting protein with the bc1 complex.   
Purified cytochrome bc1 complex is only soluble/dispersed in an aqueous solution 
in the presence of detergent. It becomes precipitate when the detergent in the system is 
removed upon dialysis.  It is expected that a soluble protein interacting with bc1 complex 
will co-precipitate with the complex when the bc1 complex becomes the precipitate upon 
dialysis. In this study, we employed the soluble/insoluble properties of the bc1 complex to 
pull down protein(s) in the matrix extract that interacts with the complex. The use of the 
dialysis/precipitation method has advantages over the commonly used antibody/antigen 
method in pulling-down interacting proteins. The antibody/antigen method depends on 
the location of the epitopes that the antibodies are against. If the epitopes are located at 
the surface of the complex where the interacting protein is associated, the antibody will 
cover the association site and thus cause false negative result. This problem will not be 
encountered when the dialysis/precipitation method is used, because the surface area in 
the bc1 complex will not be covered.  Therefore, all the interacting proteins will be 
pulled- down by using the dialysis/precipitation method.   
  Aliquots of a given amount of the detergent dispersed bc1 complex were 
incubated with various amounts of the matrix extract at 4 ˚C for 2 hours.  The mixtures 
were then dialyzed against the matrix protein buffer for 4 hours with one change of buffer 
to remove detergent and then centrifuged for 1 hour at 100,000 ×g to recover the 
precipitates of the bc1 complex. Fig.2-1-A shows the SDS-PAGE of the recovered 
precipitates after centrifugation. In addition to the subunits of the cytochrome bc1 
complex, several protein bands are observed and their intensities increased as the amount 




Fig.2-1. Identification of MDH as an interacting protein with the bc1 complex.  A. SDS 
PAGE analysis of bc1 pulled-down proteins from matrix extract. Lane 1~3, various amounts 
of MP as controls to show the proteins in the matrix extract; lane 4, standard proteins; lane 
5~6, bc1 complex and MP only as controls to show the precipitates after centrifugation; 
lane7~9, bc1 complex together with the pulled-down proteins from matrix extract. Solid arrow 
shows the main matrix protein being pulled down by the bc1 complex. Dashed arrow shows 
some other bands being pulled down by the bc1 complex. MP stands for mitochondrial matrix 
proteins; 1×, 3× and 9× stand for 0.28, 0.83 and 2.50 mg/mL of MP in the experiment; PPT 
stands for precipitates. B. MS spectra of protein sliced from SDS-PAGE gel.  Spectrum data 
were collected from a MALDI-TOF Mass spectrometer. It consisted of a series of multiple 
charged ions from each fragment on a mass-to-charge (m/z) ratio scale. 100% intensity 
represents the highest peak. C. Western blot analysis of bc1 pull-down matrix proteins with 
anti-MDH antibody. Lane 1, purified bovine mitochondrial malate dehydrogenase (MDH); 
lane 2, mitochondrial matrix extract (MP); lane 3, bc1; lane 4, the precipitate from dialyzed 





 A major protein band, whose band intensity increased as the matrix concentration 
increased, was cut out from the gel, subjected to in-gel digestion with trypsin, and 
analyzed by MALDI-TOF mass spectrometry.  
 This protein was identified as bovine mitochondria MDH based on Peptide Mass 
Fingerprinting (PMF) analysis (Fig.2-1-B). The identity of the mitochondrial MDH was 
further confirmed by Western blotting using a polyclonal antibody against the 
mitochondrial MDH (Fig.2-1-C). As expected, a protein band with an apparent molecular 
mass of 35 kDa corresponding to mitochondrial malate dehydrogense was detected in the 
matrix extract and in the bc1 precipitate fraction as the positive control. The other two 
minor bands that were indicated by the dotted arrows in Fig.2-1-A were also identified by 
MS. The larger one was aspartate transaminase, but the smaller one was not identified by 
MS due to the contaminant of the adjacent band. 
 
2.4.3 Effect of MDH on the activity of the cytochrome bc1 complex.   
As shown in the previous section, the mitochondrial matrix extract has the ability to 
enhance bc1 activity.  If MDH in the matrix extract is indeed responsible for interaction 
with the bc1 complex, one would expect to see an increase of bc1 activity upon addition 
of purified MDH.  Purified mitochondrial MDH, purchased from Sigma, was incubated 
with the cytochrome bc1 complex and the activity of ubiquinol- cytochrome c reductase 
was assayed.  As shown in Fig. 2-2, the activity of the bc1 complex increases as the MDH 
concentration in the incubation mixture increases.  This result indicates that MDH is 
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indeed one of the major proteins in the matrix extract interacting with bc1 complex to 
enhance the complex activity.  
 
2.4.4 Binding between MDH and cytochrome bc1 complex.   
The binding kinetics of MDH to bc1 was studied by Surface Plasmon Resonance 
using a SensiQ machine. MDH was bonded to the COOH chip, and different 
concentrations of bc1 complex were run through the MDH channel and control channel.  
Data analysis showed that the KD for the interaction between bc1 complex and MDH is 
about 0.047 μM (Fig.2-3), indicating a strong interaction. The interaction is buffer 
concentration dependent. At a 100 mM Na+/K+ phosphate buffer, the KD is 0.047μM; at a 
50 mM Na+/K+ phosphate buffer, the KD is 0.027μM. The fact that MDH interacts better 
with the bc1 complex in a lower buffer concentration than a higher one, indicates that the 














Fig. 2-2. Effect of MDH concentration on the bc1 complex activity.  A given amount of 
bc1 complex was added to different amounts of MDH to give the indicated molar ratios.  After 
the mixtures were incubated on ice for 20 min, the bc1 activity was determined. The activity of 














Fig. 2-3. Surface Plasmon Resonance analysis of the interaction between bc1 complex 
and MDH. The bc1 complex was diluted with the flowing buffer to give concentrations of 
8.75, 17.5, 35, and 70 nM.  The flowing buffer used was 100 mM Na+/K+ phosphate buffer, 
pH 7.4, containing 0.01% KDOC.  Aliquots of 100 μL of diluted bc1 at indicated 
concentrations were injected into both the control channel and MDH bound channel. The 








2.4.5 Identification of the subunits in bc1 complex that interact with MDH.   
To identify the subunit(s) in the bc1 complex that interacts with MDH, a biotin 
labeled transfer cross-linker, Sulfo-SBED, was used as described in the experimental 
procedures. Fig.2-4-A shows the SDS-PAGE and the Western blotting analysis of Sulfo-
SBED labeled MDH photolyzed alone and in the presence of the bc1 complex followed 
by β- mercaptoethanol treatment. The strepavidin horseradish peroxide conjugate was 
used to probe proteins having a transferred biotin tag. Four protein bands, with apparent 
molecular masses of 53, 51, 35, and 21 kDa were shown in the SDS-PAGE part around 
15~60 kDa region. The detection of the transferred biotin tag in MDH itself is expected 
in the Western blotting as the 35 kDa band, because MDH works as a dimer. The other 
three bands in the Western blotting had the same molecular masses as Core I, II and ISP. 
The band of Cyt c1, which showed in this SDS-PAGE, and the band of Cyt b, which did 
not show clearly in the SDS-PAGE, were not found in the Western blotting. Other small 
subunits which are smaller than 15 kDa were not detected by the Western blotting (not 
shown in this range of the SDS-PAGE). The identification of Core I, II and ISP in the bc1 
complex as the interaction partner for MDH is in line with the 3-D structure of the bc1 




Fig. 2-4. SDS-PAGE and Western blotting of sulfo-SBED cross linked MDH and bc1.  A. 
Ten µg of MDH in 100 µl of 50 mM Na+/K+ phosphate buffer, pH 7.4 was incubated with 
sulfo-SBED for 2 hrs on ice in the dark then dialyzed against 500 mL of a 50 mM Na+/K+ 
phosphate buffer, pH 7.4, in the dark to remove any un-reacted sulfo-SBED.  The chemically 
labeled MDH was then incubated without and with 30 μg of bc1 in 200µl of a 50 mM Na+/K+ 
phosphate buffer, pH 7.4, on ice for 1 hr.  After incubation, the mixtures were photolyzed with 
a long wavelength UV light (365 nm) at a distance of 5 cm for 15 minutes.  The photolyzed 
samples were treated with ß-ME and subjected to SDS-PAGE and Western blotting. The 
biotin tags were probed with avidin-horseradish peroxidase conjugate. B. The interaction 




Core I and II account for a major portion of the matrix part of the bc1 complex. Subunits 
VI, IX, the N-terminal parts of subunit VII and V (ISP), and the C-terminal part of 
subunit IV (cytochrome c1) are also part of it. Since the mitochondrial MDH is an 
enzyme of the citric acid cycle and is located in the matrix, interaction of MDH with the 
bc1 complex through Core I and II in the matrix region is expected. Furthermore, the 
involvement of Core I and II in the interaction with MDH is in line with the finding of the 
interaction being hydrophilic, since MDH and Core I & II of the complex are covered 
with charged amino acid residues.  Although ISP was mainly in the inter-membrane 
space, the N terminus was still exposed in the matrix, therefore, MDH could bind with 
this N terminus as shown in Fig. 2-4-B. Because ISP plays an important role in the 
electron transfer within the bc1 complex, this interaction indicates that MDH would have 
a chance to affect the electron transfer through ISP or ISP could transfer some signal to 
MDH through this crowbar-like N terminus.  
 
2.4.6 Cytochrome bc1 complex increases the activity of MDH unidirectionally (OAA to 
malate).   
Since the binding of bc1 complex with MDH enhances the bc1 activity, it was of 
interest to see whether or not this binding could affect the MDH activity. MDH catalyses 
not only the oxidation of malate to oxalacetate (forward reaction) but also the reduction 
of oxalacetate to malate (reverse reaction); both activities were investigated.  When MDH 
was incubated with varying concentrations of bc1 complex, no increase in activity of 
MDH of the forward reaction was observed (see Fig. 2-5-A). On the other hand, the 
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reverse reaction activity of MDH increased as the bc1 concentration increased (see Fig. 2-
5-B). A maximum activation of 140% was observed in the reversed reaction. The 
activation was found to be ionic strength dependent. When the ionic strength increased, 
the extent of activity enhancement decreased (see Fig. 2-6). This confirmed that the 
interaction was hydrophilic.   
The activity of bc1 complex can be affected by its inhibitors such as stigmatellin, 
antimycin A, or zinc ion (15-17). When MDH was incubated with bc1 complex treated 
with its inhibitors, only a partial enhancement of MDH reversed activity was observed 
(Table 2-2). Similarly, when bc1 complex was incubated with chlorothricin-treated MDH 
(18), no enhancement of bc1 activity was observed. These results indicated that only 
active cytochrome bc1 complex and MDH can have an effect on each other’s activity 




Fig. 2-5. Effect of bc1 complex on the activity of forward reaction (from malate to 
oxalacetate) and reversed reaction (from oxalacetate to malate ) of MDH.  Varying 
amounts of bc1 complexes were incubated on ice for 20 minutes with a given amount of 
MDH to give indicated molar ratios.  The mixtures were then subjected to assay for MDH 
forward (A) and reversed (B) activities.  The activity of MDH in the absence of bc1 was used 









Fig. 2-6. Effect of ionic strength on reverse MDH activity enhancement by bc1.  MDH 
only or together with bc1 complex in 100 mM Na+/K+ phosphate buffer, pH 7.5, was 
incubated with indicated concentrations of NaCl on ice for 30 minutes before MDH activity 
(the reverse reaction) was determined.  The activity of MDH only was used as 100%. N=4, 










Table 2-2.  Effect of MDH activity upon interaction with intact and the inhibitor treated 




(mmol /min/mg ) 
Enhancement ( 
% ) b 
MDH + Buffer c 1.77 ± 0.06  0 ± 3 
MDH + Inhibitor d 1.75 ± 0.07 -1 ± 4 
MDH + bc1 2.46 ± 0.11 39 ± 6 
MDH + bc1 + QH2 + cyt c 2.49 ± 0.13 41 ± 7 
MDH + ( bc1 + Stigmatelin ) 2.05 ± 0.08 16 ± 5 
MDH + ( bc1 + Antimycin A 
) 2.12 ± 0.06 20 ± 3 
MDH + ( bc1 + Zinc ion ) 1.84 ± 0.14  4 ± 8 
 
a, Stigmatelin-, antimycin A- or zinc ion (ZnCl2)-treated bc1 complex was incubated with MDH 
and assayed for MDH activity.  
b Enhancement of MDH activity at the reversed reaction. N=3, means ± SE. 








2.4.7 Cytochrome bc1 complex changes the enzyme kinetics of MDH.   
It was interesting to see whether the kinetics of MDH under this unidirectional 
enhancement changed or not. The Km for NADH and the Vmax for the reverse direction of 
MDH were determined by Lineweaver-Burk plots. The Km for NADH decreased from 
22.2±0.5 μM to 15.4 ± 0.5 μM and the Vmax increased from 1.6± 0.2 mmol/min/mg to 
2.5±0.2 mmol/min/mg when bc1 complex was added to MDH (Table 2-3 and Fig. 2-7). 
Also the Km of OAA decreased from 10.7±0.7 μM to 8.9±0.9 μM and the Vmax increased 
from 2.2±0.1 mmol /min/mg to 3.5±0.1 mmol /min/mg (Table 2-3 and Fig. 2-8). A 
similar kinetics analysis was also carried out in the forward direction, but no significant 
difference was detected. Therefore, the binding of bc1 complex might induce some 
conformational change of MDH, and thus lower its Km for NADH and OAA, and 












Table 2-3.  Kinetics analysis of the MDH in the present of bc1 complex. 
 
Enzyme NADH OAA 
 
Km 
( μM ) 
Vmax 
( mmol/min/mg ) 
Km 
( μM ) 
Vmax 
( mmol/min/mg ) 
MDH 22.2±0.5 1.6±0.2 10.7±0.7 2.2±0.1 
MDH + bc1 15.4±0.5 2.5±0.2 8.9±0.9 3.5±0.1 
 
0.1mM, 0.05mM, 0.025mM, 0.016mM, 0.0125mM of NADH and 0.2 mM OAA were used in 
the assay for analyzing the Km of NADH. 0.1mM, 0.025mM, 0.0125mM, 0.00625mM of OAA 
and 0.2 mM NADH were used in the assay for analyzing the Km of OAA. MDH only or 
together with bc1 complex was used in both of the assays and Vmax was also calculated via 

















Fig. 2-7. Lineweaver Burk plots for the MDH reverse directional activity by the change 
of NADH. 0.1mM, 0.05mM, 0.025mM, 0.016mM, 0.0125mM of NADH and 0.2 mM OAA 
were used in the assay for analyzing the Km of NADH. All values (presented in Table III of 














Fig.2-8. Lineweaver Burk plots for the MDH reverse directional activity by the change 
of OAA. 0.1mM, 0.025mM, 0.0125mM, 0.00625mM of OAA and 0.2 mM NADH were used in 
the assay for analyzing the Km of OAA. All values (presented in Table III of main text) are 










2.4.8 The crosstalk may regulate the mitochondrial bioenergetics.   
The cell regulates the ATP generation in mitochondria depending on the energy 
requirements of different situations. When the cell needs less ATP, mitochondria will 
slow down the citric acid cycle and thus slow down the ATP generation via the decrease 
of electron transport and ATP synthase activity. Based on the present work, we 
hypothesize that when the cell needs to slow down the ATP generation, it triggers the 
crosstalk between MDH and the bc1 complex (See Fig. 2-9). Once the bc1 complex binds 
to MDH, it will enhance the reversed activity of MDH and thus decrease the OAA 
concentration in the matrix. Since OAA is the crucial member of the citric acid cycle, a 
decrease in its concentration will result in lowering the concentrations of NADH and 
FADH2, which are substrates of Complex I and II in the electron transport chain, 
respectively. The decrease in the electron transfer activity resulting from the limited input 
of substrates will yield a negative regulation of ATP generation.  At this moment we offer 
no good explanation on why the interaction between the bc1 complex and MDH enhances 
the bc1 activity, but to speculate that the regulation of cellular energy metabolism may 










Fig. 2-9. The schematic illustration for the crosstalk between MDH and bc1 Complex. 
Solid arrows show the reactions in the matrix. Dashed arrow in the membrane stands for the 
electron transport. Dashed arrow in the matrix stands for the NADH generation form the citric 









The crosstalk could also be involved in the gluconeogenesis or in helping the 
correction of mitochondrial dysfunction during dypoxia/ reoxygenation(30). In the 
gluconeogenesis, the substrate OAA can not get out of mitochondria directly by itself. It 
has to be converted into malate first via the reversal of the citric acid cycle catalyzed by 
MDH. Once the malate is transported into the cytosol, it is converted to OAA and yields 
NADH by cytosolic MDH.  
What is still yet to be resolved is the molecular mechanism associated with this 
crosstalk between the bc1 Complex and MDH. Since it apparently plays an important role 
in controlling ATP generation, it is likely that some factors or signals are responsible for 
the regulation of the enhancing or breaking up the interaction. Work of determining the 
molecular mechanism of this crosstalk is undergoing in our laboratory. 
2.4.9 Discussion about our new precipitation pull-down technique 
Most of the proteins need to bind with other proteins and affect each other’s 
biological functions. Therefore, the methods of studying protein-protein interaction are 
very important to most of the biological research field.  Here we will discuss some 
popular assays and compare them with our new precipitation pull-down technique. 
Coimmunoprecipitation (Co-IP), a traditional method for detection of protein-
protein interactions, has been employed in many experiments.  In the Co-IP experiment, 
after antibody is added to the cell lysates, the antigen is precipitated with bound proteins 
which can be analyzed. Purified protein or synthetic peptide coupled to the carrier can be 
used as antigen for antibody production. Alternatively, an epitope tag, the antibodies of 
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which are commercially available, can be fused to the protein; or a protein tag which is 
able to bind to the beads can also be used in the Co-IP experiment. (19) 
There are several advantages for coimmunoprecipitation using crude lysates. First, a 
built-in specificity control exists in the experiment due to the presence of all the 
competing proteins in the crude lystate. Second, the proteins exist in the same 
proportional concentrations as in the cell. Third, the protein complexes are in their natural 
state, which might not be easy to assemble in vitro. Fourth, the proteins have natural 
posttranslational modifications which might be required for the protein interaction. There 
are also some apparent disadvantages. First, the coimmunoprecipitating proteins might 
not have direct interactions with the antigen. Second, monoclonal antibodies are needed 
in this experiment. If the proteins you study do not have these monoclonal antibodies, it 
would be a difficult way to get the antibodies first. Third, Co-IP is not very sensitive, 
when compared with some other methods, like protein chromatography. 
It may be a good idea to use anti-bc1 antibody to pull down proteins from the matrix 
extraction. However, this method still has other disadvantages for the possible interacting 
proteins. First, the antibody could just bind to the interaction sites where the possible 
proteins need to bind or in other words, the antibody can compete with other proteins to 
bind with bc1 complex, thus we may obtain some false negative results. Second, even if 
the antibody does not bind to the exact binding sites, its huge molecular weight can still 
cause big problems for other proteins to interact with bc1 complex, especially when such 
polyclonal antibodies generated from rabbit are used, which may bind and cover most 
parts of the surface of bc1 complex.  
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 Two-Hybrid System (20-22) uses transcriptional activity to assay protein-protein 
interaction. It is based on the nature of some site-specific transcriptional activators, 
consisting of a transcriptional activation domain and a DNA-binding domain (23-25). 
The DNA binding domain is used to bind specific genes, and the activation domain 
activate transcription by collecting other necessary proteins of the transcriptional 
machinery. The two domains do not need to be linked covalently and can come together 
by protein-protein interaction. Two hybrids are constructed for the application of the 
method. The two domains are fused to proteins X and Y individually. If the two proteins 
have interaction with each other, they will be brought together to initiate the transcription 
of the reporter gene. If the genes of the candidate proteins are available, we can use yeast 
two-hybrid to detect their interaction (26, 27).  
There are some limitations for yeast two-hybrid screens. First, it can only study 
soluble proteins and is not feasible to study integral membrane proteins’ interaction. 
Second, the fusion proteins must be able to enter the nucleus because they need to work 
as a whole transcription activator. Third, by constructing fusion proteins, the site essential 
for protein-protein interaction might be occluded. Fourth, if the post-translational 
modification necessary for the interaction does not happen in yeast cells, the protein-
protein interaction can not be detected. 
For Yeast two-hybrid method, it is good to be used to study interaction between 
small proteins, at least soluble proteins, because its mechanism is based on the fusion 
proteins which can still work as a whole transcriptional factor within the nucleus. 
However for our bc1 complex, which is a huge membrane protein with MW around 480k, 
it is impossible to use such yeast two hybrid method.  
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Pull down assays-"Pull-down" is a technique which employed some other affinity 
system other than functional antibody and it is similar to immunoprecipitation (IP). Here, 
glutathione agarose beads or metal chelate agarose beads are used to capture GST-tagged 
protein or His-tagged protein. The fusion-tagged protein functions as the "bait" to acquire 
its binding partner ("prey"). In a typical pull-down assay, the bait protein is added to a 
cell lysate; after extensive washing, the "preys" are selectively eluted which can be 
analyzed in-gel or by Western blot. His-Tag or GST-Tag pull down assay can be used in 
many protein-protein interaction studies. However, our bc1 complex is purified from 
bovine mitochondria and has no tag on it. Therefore, we can not use this normal pull 
down assay. 
Precipitation pull-down technique- Cytochrome bc1 complex is a membrane protein 
and it can only be soluble when there is detergent in the solution. If it lacks the detergent, 
bc1 complex will aggregate together and become precipitate in the solution. When bc1 
complex become precipitate, they use their trans-membrane parts to bind each other and 
then aggregate together. In this case, the matrix parts are exposed outside to face the 
solution just like the detergent’s hydrophilic part. However, we actually just want to 
study the interaction between this matrix part and other soluble proteins in the matrix. 
Therefore, the precipitate itself does not affect the interaction between the bc1 matrix part 
and other proteins. This method is good for those membrane proteins which contain a 
large portion other than its trans-membrane part and it has a potential to bind with other 
soluble proteins.  
However this method may also contain some insufficient points like all the other 
interaction assays. Non-specific binding is a common issue for all these assays. For our 
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assay, when the membrane protein forms precipitate, some soluble proteins may also be 
non-specifically pulled down by this big precipitating complex.  Thus, further 
confirmation need to be done to make sure that this binding is specific or non-specific. 
We have at least two approaches to check if the interaction is specific or not. First, the 
soluble proteins and bc1 complex recovered in the precipitates by the dialysis/ 
precipitation method can be re-solubilized and their activities can be determined. And 
this can also show us whether the interacting proteins can affect each others’ activity. 
Therefore, we can know if this interaction is functional or just non specific binding. 
Second, for non specific binding, it is unsaturable. The possibility of non-specific binding 
can be excluded if bc1 can only pull down certain amount of interacting proteins even 
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ACONITASE SCAVENGES SUPEROXIDE GENERATED FROM THE 



















Another matrix protein, pulled down by the bc1 complex using the dialysis pull-
down method, was identified by MALDI-TOF Mass spectrometry as mitochondrial 
aconitase.  Using the crosslinking technique, subunits II (core II) of the bc1 complex was 
identified as the interacting site for aconitase.  When purified aconitase was incubated 
with the detergent dispersed bc1 complex, a slight increase in aconitase activity, but no 
change in bc1 activity was observed. Upon the binding of aconitase, the superoxide 
generating activity of bc1 complex is greatly decreased. However, when aconitase was 
added to the bacterial bc1 complex, little effect on its superoxide generating activity was 
observed.  The lack of core subunits I and II in the bacterial bc1 complex may be the 
reason for this difference.  The interaction between bc1 complex and aconitase can be 
enhanced by calcium, which is considered as an active factor for mitochondrial 
bioenergetics process. These results suggest that the interaction between mitochondrial 
bc1 complex and aconitase might play an important role in superoxide scavenging when 
mitochondria is in a high energy producing state, which is crucial for mitochondria and 
the whole organism. 
3.2 Introduction 
With the dialysis pull-down technique (1), we found that soluble proteins from the 
mitochondrial matrix interacting with detergent dispersed bc1 complex can co-precipitate 
with bc1 complex upon removal of detergent by dialysis followed by centrifugation. 
Several matrix proteins were pulled down in the precipitates. One of the proteins was 
identified as MDH (1).  Another protein pulled-down was identified as aconitase, by 
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MALDI-TOF Mass spectrometry.  Aconitase (EC 4.2.1.3) catalyzes the reversible 
conversion between citrate and isocitrate via cis-aconitate as the intermediate. Although 
the catalytic function of aconitase involved non-redox- active process, it contains a 
covalently bound [4Fe-4S] iron-sulfur cluster.  The iron sulfur cluster is required for both 
the catalytic and the superoxide scavenging activities (2).  
Herein we report the identification of aconitase as one of the matrix enzymes that 
interacts with bc1 complex, the interaction between aconiatse and the bc1 complex, and 
the effect of bc1 complex on the superoxide scavenging activity of the aconitase. 
 
3.3 Experimental procedures 
Chemicals-- Cytochrome c (horse, type III), sodium cholate, sodium citrate, 
isocitrate dehydrogenase, NADP+, and porcine aconitase were purchased from Sigma. 
Cross linker, Sulfo-SBED (Sulfosuccinimidyl-2- [6-(biotinamido)-2-(p-azidobenzamido) 
hexa- noamido ] ethyl-1,3´- dithiopropionate) was purchased from Pierce.  2,3-
Dimethoxy-5-methyl-6-(10-bromodecyl)-1,4-benzoquinol (Q0C10BrH2) was prepared as 
previously reported (3). 
Cytochrome bc1 complex preparation and activity assay— Preparation of bovine 
heart mitochondrial cytochrome bc1 complex, the concentration determination of 
cytochromes b and c1, and the activity assay for mitochondrial bc1 complex were the 
same as in chapter II.  
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The his6-tagged, wild type R. sphaeroides cytochrome bc1 complex was prepared as 
previously reported (4). A condition similar to that used for the mithochondrial complex 
was used for the assay of the bacterial complex, except that the bacterial complex was 
diluted with 50 mM Tris-HCl, pH 8.0, containing 200 mM NaCl and 0.01% DM to a final 
concentration of cytochrome b of 1 μM.  
Superoxide detection –Superoxide production by the bc1 complex in the presence and 
absence of aconitase was detected by measuring the chemiluminescence of MCLA-O2  
adduct (5). An Applied Photophysics stopped-flow reaction analyzer SX.18MV-R 
(Leatherhead, UK) was used for the assay by leaving the excitation light off and 
registering light emission (6). Reactions were carried out at 23 °C by mixing 1:1 of 
solutions A and B. Solution A contains 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 mM 
EDTA, 1 mM NaN3, 0.1% bovine serum albumin, 0.01% DM, and 5.0 μM cytochrome 
bc1 with or without aconitase, Solution B contains 125 μM Q0C10BrH2 and 4 μM MCLA 
in the same buffer. The produced fluorescence was consecutively monitored for 2s once 
the reaction started. One volt equals the chemiluminescence (maximum peak height of 
light intensity) produced by 0.5 unit of xanthine oxidase which uses 100 μM 
hypoxanthine as a substrate in the Applied Photophysics stopped-flow reaction analyzer 
SX.18MV-R. 
Aconitase Activity assay-- The activity of aconitase was determined as described in 
(7). Briefly, aconitase alone or together with bc1 complex were added in the reaction 
buffer consisting of 50 mM Tris-HCl (pH7.4), 5 mM cis-aconitate, 0.6mM MnCl2, 
0.2mM NADP+, and 1 unit isocitrate dehydrogenase. The reaction was followed by the 
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reduction of NADP+ (the increment of the absorption at 340nm) in a Shimadzu UV-
2401PC spectrophotometer at 25 °C, using an extinction coefficient of 6.2 mM-1cm-1. 
Biotin-labled Aconitase Pull down-- 150ul aconitase solution (33 mg/ml) in 
phosphate buffer, was incubated with 3 mg NSH-biotin-linker, and the sample was 
incubated on ice for 2 hour. Then it was dialysised against 1L matrix protein buffer (1) to 
remove the extra soluble biotin-linker. Centrifuge at 100,000 ×g for 40 min to remove 
any denatured protein.  Final protein was stored in -80℃ for later use. Twenty µL of 
Biotin- aconitase and 7 µL bc1 complex ( 150 µM cyt b) were incubated in 500 µL MP 
buffer for 1 hr on ice. Then the mixture was dialyzed against 1L MP buffer for 3 hour to 
remove the detergent. After dialysis, the mixture was centrifuged down at 100,000 ×g for 
40 min. And make sure that the supernatant was completely removed. Re-desolve the 
precipitate with phosphate buffer containing 1% KDOC for the following experiments.  
 
Mass Spectroscopy, Cross linkingand and Western blotting are the same methods 







3.4 Results and discussion 
 
3.4.1 Identification of mitochondrial  aconitase as an interacting protein with the bc1 
complex.  
Aliquots of a given amount of the detergent dispersed bc1 complex were 
incubated with various amounts of the matrix extract at 4 ˚C for 2 hours.  The mixtures 
were then dialyzed against the matrix protein buffer for 4 hours with 3 changes of buffer 
to remove the detergent, and then centrifuged at 100,000 ×g for 1 hour to recover the 
precipitates of the bc1 complex. Fig. 3-1A shows the SDS-PAGE of the recovered 
precipitates of bc1 complex under the UV light. In addition to uv bands shown by the 
cytochrome bc1 complex, a protein band was observed and its intensity increased as the 
matrix proteins used in the incubation increased. This protein band was cut out from the 
gel, subjected to in-gel digestion with trypsin, and analyzed by MALDI-TOF mass 
spectrometry. This protein was identified as bovine mitochondria aconitase based on 











Fig. 3-1  Identification of Aconitase as an interacting protein with the bc1 complex.  A. 
SDS PAGE analysis of bc1 pulled-down proteins from matrix extract under the UV light. Lane 
1, standard proteins; lane 2~3, bc1 complex and MP only as controls to show the precipitates 
after centrifugation; lane 4~9, bc1 complex together with the pulled-down proteins from matrix 
extract under the UV light. Solid arrow shows the main matrix protein being pulled down by 
the bc1 complex. B. MS spectra of protein sliced from SDS-PAGE gel.  Spectrum data were 
collected from a MALDI-TOF Mass spectrometer. It consisted of a series of multiple charged 
ions from each fragment on a mass-to-charge (m/z) ratio scale. 100% intensity represents 
the highest peak.  
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To further confirm the interaction between aconitase and bc1 complex, purified 
bovine aconitase is need for the interaction study. However, expression of bovine 
aconitase in BL21 system did not work due to its huge molecular weight (80k). And there 
is no commercial bovine aconitase available. But the porcine aconitase shares 98% 
sequence identity with the bovine aconitase and is available from Sigma-Aldrich. Thus, 
purified porcine aconitase was used in the pull-down experiment. However, this 
commercial aconitase is only about 60% purity and the co-precipitation was very weak. 
Later, we changed it to another commercial aconitase from Japan.  We detected the 
pulled-down aconitase by bc1 complex through western blotting. Since the anti-aconitase 
antibody did not work well in the western blotting, a biotin-labeled aconitase was used 
instead (Fig. 3-2, upper).  
 
The effect of ionic strength and calcium iron on the amount of aconitase pulled 
down by bc1 complex was studied. Fig, 3-2 shows the differences of the amount of 
aconitase pulled-down by bc1 complex under various conditions. When the ionic strength 
increased, especially when calcium ion is present, a tighter interaction between aconitase 
and bc1 complex was observed indicating that the interaction between aconitase and bc1 












Fig.3-2 SDS-PAGE and Western blotting of biotin-labeled aconitase pulled down by 
bc1 complex in high salt and calcium environment. With the method described in the 
material and method part, we incubated and dialyzed bc1 complex together with biotin-
labeled aconitase with vary solutions (normal MP solution, MP solution containing 200 mM 
NaCl or MP solution containing 10 mM Calcium). Bottom figure shows the SDS-PAGE result 
of the precipitates obtained from the pull-down assay. The figure on the top shows the 
corresponding western blotting result of biotin-labeled aconitase pulled-down by bc1 






The effect of redox state of bc1 complex on the interaction between aconitase and 
bc1 complex was studied as Fig. 3-3. Since bc1 complex has different redox states, it is of 
interest to see whether the redox state affects the interaction or not. The purified bc1 
complex from bovine heart mitochondria is about 10% reduced. To obtain the fully 
reduced form, bc1 complex was treated with succinate and complex II on ice over night. 
Instead, cyt c and cyt c oxidase were used for oxidizing bc1 complex, However, no matter 
the fully reduced or the fully oxidized bc1 complex was used for the assay, the amount of 
aconitase pulled down was comparable to that pulled down by the untreated bc1 complex. 
The results indicate that the interaction does not depend on the redox state of the 

















Fig. 3-3 Western blotting of biotin-labeled aconitase pulled down by reduced and 
oxidized bc1 complex. bc1 stands for 10% reduced form of purified bc1 complex; Re- bc1 
stands for bc1 complex reduced by succinate and complex II; Ox- bc1 stands for bc1 complex 
oxidized  by cytochrome c and complex IV. Lanes marked as bc1 and ACON are the two 









3.4.2 Identification of the subunits in bc1 complex that interact with aconitase.  
To identify the subunit(s) in the bc1 complex that interacts with aconitase, a biotin 
labeled transfer cross-linker, Sulfo-SBED from Pierce, was used (1).  Fig. 3-4A shows 
the SDS-PAGE and the Western blotting analysis of Sulfo-SBED labeled aconitase 
illuminated by UV in the presence or absence of the bc1 complex. The UV activated 
samples were treated with β-mercaptoethanol before subjected to SDS-PAGE. The 
horseradish peroxide conjugated streptavidin was used to probe proteins having a 
transferred biotin tag. Three protein bands, with apparent molecular masses of 70-, 54- 
and 51KD were shown to contain the biotin tag in the western blotting.  The 70KD band 
is aconitase and 51KD band is core II of the bc1 complex.  The 54 KD band is from the 
aconitase preparation albeit its similar molecular mass to the core I (53KD) of the bc1 
complex.  The identification of subunit II in the bc1 complex as the interaction partner for 
aconitase is in line with the 3-D structure of the bc1 complex (shown as Fig.3-4B). 
Subunits I and II account for a major portion of the matrix part of the bc1 complex. Since 
the mitochondrial aconitase is an enzyme of the citric acid cycle and locates in the matrix, 






















Fig. 3-4  SDS-PAGE and Western blotting of sulfo-SBED cross linked Aconitase and 
bc1.  A. Ten µg of aconitase was incubated with sulfo-SBED for 120 minutes on ice in the 
dark followed with desalting. Labeled aconitase was then incubated with 30 μg bc1 complex 
for 60 minutes and the mixture was exposed to ultraviolet light (365 nm) at a distance of 5 
cm for 15 minutes. The photolyzed samples were treated with ß-ME and subjected to SDS-
PAGE and Western blotting. Aconitase with sulfo-SBED was the control. The extra band in 
the western blot is the subunit of bc1 complex which got the transferred biotin from 
Aconitase. The blots were probed with streptavidin-horseradish peroxidase conjugate. B. 





3.4.3 Effect on the activities of the cytochrome bc1 complex and aconitase upon 
interaction. 
In the previous chapter, we reported that bc1 complex and Malate dehydrogenase 
have crosstalk, which means they can affect each other’s activity (1). It is interesting to 
see whether such crosstalk between bc1 complex and aconitase exists. Fully reduced bc1 
complex was used for the assay to prevent the reduction of cyt c1 and mimic the 
physiologic condition in which aconitase is not accessible to the intermembrane space 
part of bc1 complex.  Fig. 3-5 shows that in the presence of fully reduced bc1 complex, 
the activity of aconitase was increased about 20%. However, no effect was found on the 
electron transfer activity of bc1 complex by interacting with aconitase. To make sure 
there is no effect on the very early time of the reaction, stop-flow was used to check the 
presteady state reduction of cytochrome b and cytochrome c1 (shown as Fig.3-6). The 
rates of the reduction of cytochorme b and c1 are similar regardless aconitase is present or 
not.  These results indicate that binding of aconitase to bc1 complex has no effect on its 
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Fig. 3-5  Effect of bc1 complex on the activity of aconitase. According to the method 
described in the material and method part, aconitase only or aconitase together with bc1 
complex were added separately in the aconitase activity assay mixtures. Data was obtained 
from the reduction of NADP at 340nm. The sample of substrates with bc1 complex in the 



















































Fig.3-6 Time courses of cytochrome b and c1’s reduction by Q0C10BrH2. A. Cytochrome 
b’s reduction by Q0C10BrH2 when aconitase was present or not. B. Cytochrome c1’s 
reduction by Q0C10BrH2 when aconitase was present or not. Aconitase itself was used as 






3.4.4 Aconitase scavenges superoxide generated by bc1 complex.  
The cytochrome bc1 complex is one of the two major sites that generate superoxide 
during the process of electron transfer in the mitochondrial electron transport chain (8). 
Aconitase is known to have superoxide scavenge activity (9).  It is interesting to see 
whether aconitase in complex with bc1 complex can prevent or decrease the superoxide 
generation from the latter or it can scavenge superoxide after release.  Fig.3-7A shows the 
effect of aconitase on generation of superoxide by cytochrome bc1 complex. The amount 
of superoxide generated by a given amount of bc1 complex decreased as the amount of 
aconitase used increased. However, when the same assay was carried out with bacterial 
bc1 complex and aconitase, only very little effect on the superoxide generation was 
observed (Fig. 3-7B). Fig. 3-7C shows the calculated relationship between the protein 
ratio and superoxide generation. In contrast to bacterial bc1 complex, the interaction 
between mitochondrial bc1 complex and aconitase is clearly specific. This is also 
indirectly confirmed by the observation that aconitase interacts with bc1 complex through 
its subunit II, which is lacking in the bacterial bc1 complex. 
The titration of bc1 complex with aconitase showed the maximal effect of aconitase 
on the generation of superoxide by bc1 complex reached around the ratio 2.4 between the 
two enzymes. This indicates that two moles of aconitase might bind per mole of bc1 
complex assuming some inactive aconitase is present in the commercial preparation. 
Since each bc1 complex contains two monomers and aconitase works only as a monomer, 
each subunit II of bc1 complex may interact with one aconitase.  
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Fig. 3-7  Effect of aconitase on the superoxide generation by the mitochondrial (A and 
■ in C) or bacterial (B and ● in C)  bc1 complex.  Various amounts of aconitase were 
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incubated with a given amount of mitochondrial bc1 complex on ice for 10 minutes.  The 
mixtures were then subjected to the assay for superoxide generation in Stop-Flow. The same 
ratio between aconitase and bacterial bc1 complex was repeated in the same assay. The 
relationship between the ratio of these two proteins and the superoxide generation was 




3.4.5 The interaction may protect the mitochondria from the damage of superoxide. 
In most organisms, there are a number of toxicities mediated by “oxidative stress.” In 
the oxidative stress, the reactive oxygen species (ROS) may interact with cellular 
constituents such as DNA/RNA, proteins, carbohydrates, and unsaturated lipids, and 
causes an irreversible damage to these components and thus induces aging and apoptosis 
(10, 11). Cumulative oxidative damage has been involved in many disease states, e.g. the 
cancer, inflammation, ischemia-reperfusion injury and so on. (12-16). The ROS, which 
include reactive radicals (hydroxyl or superoxide) and reactive non-radical species 
(singlet oxygen, peroxynitrite, and peroxide), can inactivate the iron-sulfur clusters of 
complexes I and III in the mitochondria electron transport chain leading to damage of  the 
mitochondrial respiration (17). Mitochondria have long been believed to be the primary 
site of intracellular ROS generation (18, 19).  About 1-2% of oxygen consumption 
doesn’t participate in oxidative phosphorylation, and this part is involved in the formation 
of the superoxide anion (20). Complex I and complex III are considered as the main sites 
for the superoxide production (21). In complex I, the electron donors for superoxide 
production are the flavin radical and the ubiquinone radical (22). In bc1 complex, the 
ubisemiquinone radical at the QP site (23) and the reduced heme b566 (or bL) (24) were 
considered to be responsible for electron leakage which induce superoxide production 
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during bc1 complex catalysis. More recently a mechanism which shows direct 
participation of molecular oxygen in the bifurcated oxidation of ubiquinol was suggested 
for the superoxide generation in bc1 complex (25). 
In mitochondria, the superoxide dismutases (SOD) could catalyze superoxide 
dismutation to form oxygen and hydrogen peroxide.  Recently, aconitase is found to have 
superoxide scavenging activity and the iron-sulfur cluster is essential for such scavenging 
activity (26, 27). In the present work, we found that aconitase could interact with bc1 
complex and the interaction could be involved in the superoxide scavenging process in 
mitochondria. The effect of aconitase on superoxide depletion activity could be due to 
interaction between bc1 complex and aconitase or simply due to the scavenging activity of 
aconitase. If the effect on superoxide depletion is based on their interaction, a simple 
stoichiometric relation between bc1 and aconitase should be observed. If the effect is 
resulted from intrinsic scavenging activity of aconitase and has nothing to do with its 
interaction with bc1 complex, then the effect would be aconitase concentration dependent. 
In contrast to bacterial bc1 complex, mitochondrial bc1 complex could bind aconitase 
through its subunit II and thus enhance superoxide scavenging activity. The 
stoichiometric relation between bc1 and aconitase could be 2, which indicates that each 
mitochondrial bc1 complex can bind with two aconitase. And once both of the two 
subunit II in the bc1 complex bind with aconitase, the fastest speed for aconitase to 
scavenge superoxide can be reached. However, aconitase itself can also react with 
nonspecific superoxide other than from bc1 complex. Xanthine oxidase, an superoxide 
generator, is considered as a good control here to compare with mitochondrial bc1 
complex. However, for some unknown reason, this xanthine oxidase assay was not very 
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stable. So we have to use other superoxide generator. Since bacterial bc1 complex cannot 
bind with aconitase, we used it as a nonspecific superoxide generator to confirm the 
specific interaction between mitochondrial bc1 complex and aconitase.  The superoxide 
scavenging activity is much higher when it binds with mitochondrial bc1 complex (Fig. 3-
8). Therefore, aconitase could scavenge the superoxide more effectively with the help of 
bc1 complex. And this interaction may play an important role to protect the mitochondria 

















































Fig. 3-8 Comparison of superoxide generation from mitochondrial and bacterial bc1 
complex.  A Same amount of aconitase according to figure-3-8A was used in the bacterial 
superoxide generation assay.  B Comparison of the superoxide generation in Figure 3-8A 
and Figure 3-9A. Gray line stands for bacterial bc1’s superoxide generation and black line 






At this moment we offer no good explanation on why the interaction between the 
bc1 complex and aconitase enhances its activity. It is likely that bc1 complex can stabilize 
aconitase by protecting the iron-sulfur cluster from destruction by superoxide. And it is 
also likely that bc1 complex can help aconitase to recycle from inactive state to active 
state by offering electron.  
 
When there is calcium present in the pull-down assay, more aconitase was pulled 
down by bc1 complex. Therefore, calcium may be considered as an important factor for 
enhancing this interaction.  This is also meaningful for the cell to regulate the energy 
metabolism (Fig. 3-9). Calcium is known as an activator for mitochondrial energy 
metabolism. Once the system need to be active, every member involved in the 
mitochondrial bioenergetics process should also increases their activity, and meanwhile, 
some harmful side product like superoxide should also be controlled by this system. Here 
we speculate how mitochondria regulate this complicated bioenergetics process through 
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In the database of Genbank, there are two kinds of mitochondrial malate 
dehydrogenase in bovine (Bos taurus). One is a short protein with 278 amino acid 
residues (NP_001013605.1; AAX46375.1; DAA15016.1), which is the NCBI reference 
sequence for MDH.  The other is a longer protein with 338 amino acid residues 
(AAI09598.1; Q32LG3.1). In most cases, the mitochondrial malate dehydrogenase 
reported is actually the longer form. With RT-PCR, we confirmed that both of them exist 
in bovine heart mitochondria. We expressed and purified both of the malate 
dehydrogenase in E.coli. We found that in contrast to the long MDH, the short form of 
protein does not have the activity. In our previous paper we reported that the long form of 
MDH may bind with bc1 and this interaction can down-regulate the bioenergetics in 
mitochondria. The analysis of this short MDH indicates that the database may put the 
sequence of the nonfunctional one as the NCBI reference sequence for the correct 
enzyme in the citric acid cycle. However this short MDH may help the normal long MDH 
together to regulate the bioenergetic process of mitochondria.  
 
4.2 Introduction 
Mitochondrial malate dehydrogenase (EC 1.1.1.37) catalyzes the conversion of 
malate into oxaloacetate, which is the final reaction of the citric acid cycle. The reaction 
is NAD+-dependent and oxidizes malate’s secondary hydroxyl group to a corresponding 
ketone (1). The MDH also catalyzes the reversible reaction from oxaloacetate to malate. 
The crystal structure of mitochondrial malate dehydrogenase from porcine heart has 
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already obtained. And in this MDH crystal structure, it contains four identical subunits in 
the asymmetric unit of a monoclinic cell.(2) Besides the TCA cycle, MDH also 
participates in the malate-aspartate shuttle, translocating electrons (NADH) produced 
during glycolysis across the mitochondrial inner membrane. Malate dehydrogenase has 
two forms in the shuttle system: mitchondrial malate dehydrogenase and cytosolic 
dehydrogenase. In the cytosol, malate dehydogenase catalize the reaction of oxaloacetate 
and NADH to produce malate and NAD+. Then malate is imported into mitochondrial 
matrix by the Malate-alpha-Ketoglutarate antiporter, and meanwhile alpha-ketoglutarate 
is exported from the matrix into the cytosol. Once transported into matrix, malate will be 
converted to oxaloacetate by mitochrondrial malate dehydrogenase. And NAD+ is also 
reduced to NADH (3). 
Malate dehydrogenase is also involved in gluconeogenesis, in which glucose is 
synthesized from smaller molecules. Mitochondrial malate dehydrogenase reduces the 
oxaloacetate to malate, which is transported through the inner mitochondrial membrane. 
Then malate is oxidized by the cytosolic malate dehydrogenase to form oxaloacetate in 
the cytosol, which is converted to phosphoenol pyruvate by phosphoenol pyruvate 
carboxy kinase (PEPCK) finally. (4) 
Recently, we found that MDH can bind with bc1 complex and affect each other’s 
activity. This novel crosstalk between citric acid cycle enzymes and electron transfer 
chain complexes might play a regulatory role in mitochondrial bioenergetics (5). The 
negative regulation cannot be always functional and there should be some negative 
regulator to work together with it.  In the present work, we found there is a short form of 
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MDH from mitochondria. It has the NCBI reference sequence but it does not have the 
MDH activity. It may bind with bc1 complex and break the interaction between the 
normal MDH and bc1 complex, and functions as an up-regulator for energy process. Both 
the up and down regulations together influence the TCA cycle and thus regulate ATP 
generation according to the need of organisms.  
 
4.3 Experimental procedures 
 
Chemicals- Cytochrome c (horse, type III), sodium cholate, deoxycholate, and 
bovine malate dehydrogenase were purchased from Sigma. 2,3-Dimethoxy-5-methyl- 6-
(10-bromodecyl)-1,4-benzoquinol (Q0C10BrH2) was prepared as previously reported (6).  
Cloning, expression, and purification of proteins- The recombinant proteins 
corresponding to the long-MDH, Short-MDH, C-Long, C-Short and their mutant versions 
were depicted in Fig. 4-2. The cDNAs of bovine cell were purchased from Invitrogen. All 
His-tag fusion constructs were cloned into the expression vector pET28a (a pET28a 
variant with the first his-tag coding sequence deleted) between the Xba I and Xho I sites. 
All MDH proteins were expressed in Escherichia coli strain BL21 (DE3). E. coli cultures 
were shaken at 200 rpm and 37 °C until the OD600 reached 0.5–0.7. Isopropyl β-D-
thiogalactopyranoside (IPTG) was then added to the culture at a final concentration of 
1 mM, and the protein expression was induced for an additional 4 h at 30 °C. All His-
tagged fusion proteins were purified with His•Bind® Purification Kits (Novagen). 
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Cytochrome bc1 complex preparation and activity assay, and MDH activity assay are 
the same as described in chapter II.  
 
4.4 Results and discussion 
4.4.1 Comparing the amino acid sequence of long and short MDH 
In the database of Genbank, the NCBI reference sequence for bovine MDH is 
NP_001013605.1 (or AAX46375.1; DAA15016.1) which codes for 278 amino acids 
residues MDH (including the signal peptide). However in the most publications, MDH 
has 338 amino acids (including the signal peptide), which has the sequence of 
AAI09598.1(or Q32LG3.1). The amino acid sequence alignment shows that the N-
terminal parts (1-195) of these two MDH are exactly the same (shown as Fig. 4-1).  The 
C-termini (196-278 and 196-338) are totally different, which means the short one may 
not be spliced from the longer one. The longer one (from bovine mitochondria) has 95% 
identity with the human mitochondrial malate dehydrogenase, and even 100% identity 
with the porcine MDH. Therefore, it is interesting to know whether this short bovine 






338 aa (AAI09598.1;      Q32LG3.1 ) [ Bos taurus ]
278 aa  (NP_001013605.1;      AAX46375.1;      DAA15016.1 ) [ Bos taurus ]
1 MLSALARPAG AALRRSFSTS AQNNAKVAVL GASGGIGQPL SLLLKNSPLV SRLTLYDIAH     
61 TPGVAADLSH IETRATVKGY LGPEQLPDCL KGCDVVVIPA GVPRKPGMTR DDLFNTNATI      
121 VATLTAACAQ HCPEAMICII SNPVNSTIPI TAEVFKKHGV YNPNKIFGVT TLDIVRANAF      
181 VAELKDLDPA RVNVPRHRRP RWENHHPLDL PVHPQGGISP GPADHPHRSD PGSWHRGGQG      
241 EGRSGLCHPV HGIRWSPLCL LPRGRDEWKG RSRRMFLR
1 MLSALARPAG AALRRSFSTS AQNNAKVAVL GASGGIGQPL SLLLKNSPLV SRLTLYDIAH       
61 TPGVAADLSH IETRATVKGY LGPEQLPDCL KGCDVVVIPA GVPRKPGMTR DDLFNTNATI      
121 VATLTAACAQ HCPEAMICII SNPVNSTIPI TAEVFKKHGV YNPNKIFGVT TLDIVRANAF      
181 VAELKDLDPA RVNVPVIGGH AGKTIIPLIS QCTPKVEFPQ DQLTTLTGRI QEAGTEVVKA      
241 KAGAGSATLS MAYAGARFVF SLVDAMNGKE GVVECSFVKS QETDCPYFST PLLLGKKGIE      
301 KNLGIGKVSP FEEKMIAEAI PELKASIKKG EEFVKNMK
 
Fig. 4-1 Amino acid sequence analysis for Long and Short MDH from bovine 
mitochondria. The mitochondrial location signal peptides are shown in blue; the same parts 










4.4.2 RT-PCR confirmed the existence of short MDH 
First, we needed to confirm that this short form MDH exist in bovine mitochondria. 
Since all the sequences of these MDH in the Genbank are obtained through the cDNAs, it 
is easy to design RT-PCR assay with the whole cDNAs from bovine cell as the template. 
Because there is another cytosolic MDH which also share high identity with 
mitochondrial MDH, the primers with the codes for mitochondrial location peptide are 
designed.  Both the short and long MDH bands were found (Shown as Fig. 4-2) in the 
DNA agarose gel. These bands were extracted from the gel and ligated into T-easy vector 
for sequencing. Both of them were correct with the given sequences from the database.  

















4.4.3 Expression and Purification of the long and short form MDH 
To obtain the long and short form MDH, a His-tag was added on each sequence 
through another PCR with his-tag primer (shown as Fig. 4-3). Then the proteins of long 
and short MDH were expressed in E.coli BL21 with modified vector pET-28a.  Purified 
long and short MDH were shown in SDS-PAGE and western blotting as compared to the 
one obtained from Sigma. Since the purified long MDH contains the signal peptide and 
His-tag, its molecular weight is bigger than the one purchased from sigma, which was 
purified from the bovine tissues. Surprisingly, we found that the polyclonal antibody for 
MDH can only bind with purified long MDH and the sigma one (shown in Fig. 4-4). This 
antibody may be against the C-terminus of MDH and cannot recognize the N-terminus. 
Therefore, we cannot use it to check the protein level of the short MDH in comparison 










Fig. 4-3. Schematic representation of the proteins used in this study. N stands for N-
terminus; CL and CS stand for the Long and short C-terminus. The dark gray thin bar stands 














 Fig. 4-4 SDS PAGE and western blotting results of the Long and Short MDH. *Both 
long and short MDH contain the mitochondrial signal peptide and His-tag. Anti-bovine 









4.4.4 Short MDH does not have the normal enzyme activity of long MDH 
Once the protein of the short form MDH is obtained, it is important to know whether 
the protein is enzymatic active. Since long-MDH catalyzes both forward and reverse 
reaction in the citric acid cycle, both activities of short-MDH were assayed by the same 
activity assay method. The purified Long -MDH was also checked.  The Long-MDH had 
the similar enzyme activity as the one purchased from sigma. However, Short-MDH did 
not have the normal MDH enzyme activity (Shown as Fig. 4-5). Since the short-MDH 
exists in the cell but do not have activity, it may have some important function other than 
the in the citric acid cycle.  
4.4.5 Short MDH may compete with Long MDH on the binding site of bc1 complex 
 Previous report indicated that long MDH can interact with bc1 complex and 
enhance the activity of bc1 complex. It is interesting to see whether or not the short-MDH 
has the same function.  The bc1 activity enhancement assay was carried out with the 
purified short-MDH. The results show that short-MDH can enhance the bc1 activity much 
more as compared to the long MDH (Fig. 4-6).  This result suggests that short-MDH can 
interact with bc1 complex.  The interaction or binding between the bc1 complex and 
short-MDH may be stronger than that of long-MDH.  
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malate + NAD+ ↔ oxaloacetate + NADH + H+
 
Fig. 4-5  MDH activity assay in the forward and reverse directions. The activity of Long 
MDH (L-MDH) is in red; the activity of Short MDH (S-MDH) is in blue; the activity of the MDH 


























0     1     5     10   15











However, the pull-down assay (5) using matrix proteins has failed to recover the 
short-MDH in the precipitate.   Although the short-MDH is detected in matrix proteins 
fraction, the concentration may be too low for the pull down assay. It is also possible that 
the conditions of the pull-down assay preferred by the Long-MDH may not suitable for 
the short-MDH to bind with bc1 complex.  To verify the binding between short-MDH and 
bc1 complex, recombinant short-MDH was used in the pull down assay (Fig. 4-7). In the 
SDS-PAGE, it shows clearly that short-MDH was pulled down by bc1 complex, when 
comparing bc1 only with bc1 plus short-MDH. The effect of ionic strength on the amount 
of short MDH pulled down by bc1 complex was also studied. Fig, 4-7 shows the 
difference of the amount of short MDH pulled-down by bc1 complex under 200 mM 
NaCl. When the ionic strength increased, no short-MDH was observed indicating that the 
interaction between short MDH and bc1 is hydrophilic.  
MDH was considered as a dimer in the cell. The crystal structure shows that the 
two monomers form a dimer through their N-termini. And the active site is mainly 
formed from amino acid residues from the C-terminus part. The short MDH contains the 
same N-terminus but different C-terminus and it does not have the enzyme activity. But 
the short MDH binds with bc1 complex stronger than the long MDH. If it can compete 
with Long-MDH to bind with bc1 complex, it will break the crosstalk between bc1 
complex and MDH (the long MDH) and thus have a special role in regulating the 
bioenergetic process in the mitochondria. 
It is still not clear what factor can switch between Long-MDH and Short-MDH on 






Fig. 4-7.  SDS-PAGE result of the short MDH pulled down by bc1 complex in low and 
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CO-CRYSTALLIZATION OF CYTOCHROME BC1 COMPLEX WITH 

















To study the co-complex of mitochondrial bc1 complex and malate dehydrogenase 
(or aconitase), we developed two approaches to obtain the co-crystals. The first one is to 
use bc1 to pull down MDH or ACON when bc1 becomes crystals; the second one is to use 
the soluble parts (core I and core II) of bc1 complex to get the co-crystal together with 





In chapter II and III, I reported that bovine mitochondrial bc1 complex could bind 
with mitochondrial malate dehydrogenase and aconitase. The interaction between them 
may play an important role in regulating the bioenergetic process in mitochondria. 
However, the mechanism of the interaction is still unclear. To further understand the 
interaction between those proteins, we need to know the structural information for those 
co-complexes. We have already known all the structures for these three proteins. The 
crystal structures of bovine mitochondrial bc1 complex was obtained in 1997(1), and the 
crystal structures of mitochondrial malate dehydrogenase and aconitase were obtained in 
1994 (2, 3).(Fig. 5-1) However, it is still impossible for us to simulate the co-complex 
through computer so far. Because all of them are too big for calculating and we don’t 
















Therefore we still have to get the co-crystals first to obtain the structure of co-
complex. But we don’t need very high resolution at this point, since we have already 
known their structures individually. With this aim, we have two approaches. The first one 
is aimed at getting the co-crystals by using pull-down method. As we mentioned in the 
previous chapters, bc1 can pull down the MDH and Aconitase. And we also have a 
developed method to obtain the crystal of bc1 complex. Therefore, we will try to use bc1 
to pull down MDH or ACON when bc1 forms crystals. If it works, we may see both bc1 
complex and MDH (or aconitase) in the co-crystals. The second one is aimed at getting 
co-crystals of core I or core II with MDH (or aconitase). As we reported in chapter II and 
III, core I and core II (also known as subunit I and II) of bc1 complex have the binding 
sites for MDH, and core II has the binding site for aconitase. Core I and core II are 
soluble and stable in the solution although we separate them from other subunits. We will 
express and purified the core I and core II from E.coli and try to get the co-crystals with 
MDH or Aconitase.  
With these approaches, we got some crystals and used SDS-PAGE to check 
whether the crystals contain those two proteins or not beside the bc1 complex. And the 






5.3 Experimental procedures 
Chemicals- Sodium cholate, deoxycholate, and bovine malate dehydrogenase were 
purchased from Sigma. 2,3-Dimethoxy-5-methyl- 6-(10-bromodecyl)-1,4-benzoquinol 
(Q0C10BrH2) was prepared as previously reported (4).  
Cloning, expression, and purification of proteins- The cDNAs of bovine cell was 
purchased from Invitrogen. Both core I- and core II-His-tag fusion constructs were 
cloned into the expression vector pET28a (a pET28a variant with the first his-tag coding 
sequence deleted) between the Xba I and Xho I sites. These two proteins were expressed 
in Escherichia coli strain BL21 (DE3). E. coli cultures were shaken at 200 rpm and 37 °C 
until the OD600 reached 0.5–0.7. Isopropyl β-D-thiogalactopyranoside (IPTG) was then 
added to the culture at a final concentration of 1 mM, and the protein expression was 
induced for an additional 4 h at 30 °C. All His-tagged fusion proteins were purified with 
His•Bind® Purification Kits (Novagen). 
Cytochrome bc1 complex preparation- Cyt bc1 complex from the bovine heart 
mitochondria was prepared as described in chapter II. For crystallization, an additional 
15-step ammonium acetate fractionation was carried out to remove impurities from the 
bc1 complex. Then bc1 complex was recovered from the precipitates formed between 
18.5% and 33.5% ammonium acetate saturation. The final bc1 complex was dissolved in 
50 mM Tris–HCl buffer（pH 7.8, containing 0.66 M） sucrose to a protein concentration 
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of 26 mg/ml and frozen at −80 °C until use. The concentrations of cyt b and c1 were 
determined spectroscopically, using millimolar extinction coefficients of 28.5 cm−1 mM−1 
(5) and 17.5 cm−1 mM−1 (6) for cyt b and c1, respectively.  
 
Crystallization- Purified bc1 complexes were adjusted to a final concentration of 20 
mg/ml in the crystalliztion buffer (50 mM Mops at pH 7.2, 20 mM ammonium acetate, 
20% (w/v) glycerol, and 0.16% (w/v) sucrose monocaprate). One ul of MDH (19.7 
mg/mL ) or Aconitase (21.2 mg/mL) was added into the co-crystallization solution. This 
crystallization solution with or without MDH (or Aconitase) was set up for crystallization 
as described in previous publications (1, 7).  Crystals appeared in two days by using the 
hanging drop method, and one to two weeks in the sitting drops. Both bc1 crystals and co-









5.4 Results and discussion 
5.4.1 The first approach to get the co-crystals 
Our lab has developed a stable method for crystallizing the mitochondrial bc1 
complex. And we have already obtained the purified proteins of mitochondrial bc1 
complex, malate dehydrogenase and aconitase (Fig. 5-2). Therefore, in the first approach, 
we used the same method but put the proteins together to obtain some crystals. First, we 
dialyzed MDH and aconitase against the crystallization buffer to remove their original 
buffer. Then, we concentrated those two proteins and got them in high concentration 
(MDH 19.7 mg/mL, aconitase 21.2 mg/mL). In this way, very few volume of MDH or 
aconitase would be added into the total mixture. Therefore, the conditions for 
crystallizing bc1 were only changed very little.  
With this method, we got some crystals in the hanging drop assay first (Fig. 5-3). 
And actually, when I added MDH into bc1 complex, I got the crystal faster than the bc1 
itself, and the crystals were also bigger. Then to make sure whether the co-crystals 
contain those two proteins or not, I used the SDS-PAGE to check the co-crystals. In the 
first time, I dried the crystals on the filter paper. In Fig. 5-4, it looks like the co-crystals 
contain MDH or Aconitase as compared to the crystals of bc1 only. In the second time, I 
washed the crystals several times in the similar solution for crystallization first before 
they were subjected to the SDS-PAGE. In Fig.5-5, the MDH band in the co-crystal was 
much weaker than Fig. 5-4, but all the bands were very weak. Therefore, it is still not 








Fig. 5-2 SDS-PAGE of the purified mitochondrial bc1 complex, malate dehydrogenase 






Fig.5-3 Crystals of mitochondrial bc1 complex in the presence of malate dehydrogen-










Fig. 5-4 SDS-PAGE of the co-crystals for the mitochondrial bc1 complex together with 
malate dehydrogenase and aconitase after being dried on the filter paper. 10% SDS-








Fig. 5-5 SDS-PAGE of the co-crystals for the mitochondrial bc1 complex together with 
malate dehydrogenase and aconitase after being washed in the solution. 15% SDS-










5.4.2 The second approach to get the co-crystals 
For the second approach, we need to use the matrix part core I and core II to get 
the co-crystals of bc1 complex with MDH or aconitase. Since we have already obtained 
the purified MDH and aconitase (Fig.5-2), we need to purify the core I and core II of bc1 
complex. Core I and II could be soluble by themselves and their MW are around 45 kD, 
which are not too big for expression in the E.coli. system. Therefore, we used E.coli. BL-
21 to express those two proteins. I just finished the clone part of the second approach, and 
in the SDS-PAGE (Fig. 5-6), we can see the induced expression of core I and core II 







Core I Core II
SDS-PAGEPCR
 
Fig. 5-6 PCR and SDS-PAGE results for mitochondrial Core I and II. PCR shows the 
DNA segments for the Core I and II obtained from RT-PCR of bovine heart cell cDNA. SDS-
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ADP   adenosine diphosphate 
ATP   adenosine triphosphate 
-ME   -mercaptoethanol  
cyt   cytochrome 
DNA   deoxyribonucleic acid 
E. coli    Escherichia coli 
EPR     electron paramagnetic resonance 
ISP   Iron sulfur protein 
kDa     kilodaltons 
kb     kilo base pairs 
PAGE   polyacrylmide gel electrophoresis 
PMSF    phenylmethylsulfonyl fluoride 
Pi   phosphate 
Q   ubiquinone 
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Q0C10Br  2,3-dimethoxy-5-methyl-6-(10-bromo)-decyl-1,4-benzoquinone  
Rs.   Rhodobacter sphaeroides 
MDH                             Malate dehydrogenase 
SDH     Succinate dehydrogenase 
SDS   sodium dodecylsulfate 
SMP   submitochondrial particle 
UHDBT  5-n-undecyl-6-hydroxyl-4,7-dioxobenzothiazole 
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Findings and Conclusions:   
The interactions between the mitochondrial cytochrome bc1 complex and matrix 
soluble proteins were studied by a precipitation pull-down technique. One of the matrix 
proteins pulled down by bc1 complex was identified as mitochondrial malate 
dehydrogenase (MDH) by MALDI-TOF Mass spectrometry and confirmed by Western 
blotting with anti-MDH antibody. Using cross linking technique, subunits I, II (core I & 
II) and V of the bc1 complex were identified as the interacting sites for MDH. Incubating 
purified MDH with the detergent dispersed bc1 complex results in the increase of the 
activities of both the bc1 complex and MDH. The effect of the bc1 complex on the 
activities of MDH is unidirectional (oxalacetate → malate). These results suggest that the 
novel crosstalk between citric acid cycle enzymes and electron transfer chain complexes 
might play a regulatory role in mitochondrial bioenergetics. We also confirmed the 
existence of a short form of MDH. We found that it does not have the normal enzyme 
activity but may help the normal long MDH together to regulate the bioenergetics process. 
Another matrix protein pulled down by bc1 complex was identified as mitochondrial 
aconitase. Subunit II of the bc1 complex was identified as the interacting site for 
aconitase. Unlike MDH, no effect on the activity of the bc1 complex was observed when 
purified aconitase was interacted with the detergent dispersed bc1 complex. And the 
activity of aconitase was only enhanced slightly by cytochrome bc1 complex. Upon the 
binding of aconitase, the superoxide generating activity of bc1 complex is greatly 
decreased. However, when aconitase was added to the bacterial bc1 complex, little effect 
on its superoxide generating activity was observed.  The lack of core subunits I and II in 
the bacterial bc1 complex may be the reason for this difference.  The interaction between 
bc1 complex and aconitase can be enhanced by calcium, which is considered as an active 
factor for the bioenergetic process of mitochondria. These results suggest that the binding 
between mitochondrial bc1 complex and aconitase might play an important role in 
superoxide scavenging when mitochondria is in a high energy producing state, which is 
crucial for mitochondria and the whole organism. 
To study the co-complex of mitochondrial bc1 complex and malate dehydrogenase 
(or aconitase), we developed two approaches to obtain the co-crystals. With these 
approaches, I got some crystals and am conducting further studies. 
